Hugo_Symbol	Entrez_Gene_Id	Center	NCBI_Build	Chromosome	Start_position	End_position	Strand	Variant_Classification	Variant_Type	Reference_Allele	Tumor_Seq_Allele1	Tumor_Seq_Allele2	dbSNP_RS	dbSNP_Val_Status	Tumor_Sample_Barcode	Matched_Norm_Sample_Barcode	Match_Norm_Seq_Allele1	Match_Norm_Seq_Allele2	Tumor_Validation_Allele1	Tumor_Validation_Allele2	Match_Norm_Validation_Allele1	Match_Norm_Validation_Allele2	Verification_Status	Validation_Status	Mutation_Status	Sequencing_Phase	Sequence_Source	Validation_Method	Score	BAM_file	Sequencer	Tumor_Sample_UUID	Matched_Norm_Sample_UUID	Genome_Change	Annotation_Transcript	Transcript_Strand	Transcript_Exon	Transcript_Position	cDNA_Change	Codon_Change	Protein_Change	Other_Transcripts	Refseq_mRNA_Id	Refseq_prot_Id	SwissProt_acc_Id	SwissProt_entry_Id	Description	UniProt_AApos	UniProt_Region	UniProt_Site	UniProt_Natural_Variations	UniProt_Experimental_Info	GO_Biological_Process	GO_Cellular_Component	GO_Molecular_Function	COSMIC_overlapping_mutations	COSMIC_fusion_genes	COSMIC_tissue_types_affected	COSMIC_total_alterations_in_gene	Tumorscape_Amplification_Peaks	Tumorscape_Deletion_Peaks	TCGAscape_Amplification_Peaks	TCGAscape_Deletion_Peaks	DrugBank	ref_context	gc_content	CCLE_ONCOMAP_overlapping_mutations	CCLE_ONCOMAP_total_mutations_in_gene	CGC_Mutation_Type	CGC_Translocation_Partner	CGC_Tumor_Types_Somatic	CGC_Tumor_Types_Germline	CGC_Other_Diseases	DNARepairGenes_Role	FamilialCancerDatabase_Syndromes	MUTSIG_Published_Results	OREGANNO_ID	OREGANNO_Values	i_1000Genome_AA	i_1000Genome_AC	i_1000Genome_AF	i_1000Genome_AFR_AF	i_1000Genome_AMR_AF	i_1000Genome_AN	i_1000Genome_ASN_AF	i_1000Genome_AVGPOST	i_1000Genome_CIEND	i_1000Genome_CIPOS	i_1000Genome_END	i_1000Genome_ERATE	i_1000Genome_EUR_AF	i_1000Genome_HOMLEN	i_1000Genome_HOMSEQ	i_1000Genome_LDAF	i_1000Genome_RSQ	i_1000Genome_SNPSOURCE	i_1000Genome_SVLEN	i_1000Genome_SVTYPE	i_1000Genome_THETA	i_1000Genome_VT	i_ACHILLES_Lineage_Results_Top_Genes	i_CGC_CancerGermlineMut	i_CGC_CancerMolecularGenetics	i_CGC_CancerSomaticMut	i_CGC_CancerSyndrome	i_CGC_Chr	i_CGC_ChrBand	i_CGC_GeneID	i_CGC_Name	i_CGC_OtherGermlineMut	i_CGC_TissueType	i_COSMIC_n_overlapping_mutations	i_COSMIC_overlapping_mutation_descriptions	i_COSMIC_overlapping_primary_sites	i_ClinVar_ASSEMBLY	i_ClinVar_HGMD_ID	i_ClinVar_SYM	i_ClinVar_TYPE	i_ClinVar_rs	i_ESP_AA	i_ESP_AAC	i_ESP_AA_AC	i_ESP_AA_AGE	i_ESP_AA_GTC	i_ESP_AvgAAsampleReadDepth	i_ESP_AvgEAsampleReadDepth	i_ESP_AvgSampleReadDepth	i_ESP_CA	i_ESP_CDP	i_ESP_CG	i_ESP_CP	i_ESP_Chromosome	i_ESP_DBSNP	i_ESP_DP	i_ESP_EA_AC	i_ESP_EA_AGE	i_ESP_EA_GTC	i_ESP_EXOME_CHIP	i_ESP_FG	i_ESP_GL	i_ESP_GM	i_ESP_GS	i_ESP_GTC	i_ESP_GTS	i_ESP_GWAS_PUBMED	i_ESP_MAF	i_ESP_PH	i_ESP_PP	i_ESP_Position	i_ESP_TAC	i_ESP_TotalAAsamplesCovered	i_ESP_TotalEAsamplesCovered	i_ESP_TotalSamplesCovered	i_Ensembl_so_accession	i_Ensembl_so_term	i_Familial_Cancer_Genes_Reference	i_Familial_Cancer_Genes_Synonym	i_HGNC_EnsemblGeneID	i_HGNC_HGNCID	i_HGNC_RefSeqIDs	i_HGNC_Status	i_HGNC_UCSCIDsuppliedbyUCSC	i_ORegAnno_bin	i_UniProt_alt_uniprot_accessions	i_annotation_transcript	i_build	i_ccds_id	i_dbNSFP_1000Gp1_AC	i_dbNSFP_1000Gp1_AF	i_dbNSFP_1000Gp1_AFR_AC	i_dbNSFP_1000Gp1_AFR_AF	i_dbNSFP_1000Gp1_AMR_AC	i_dbNSFP_1000Gp1_AMR_AF	i_dbNSFP_1000Gp1_ASN_AC	i_dbNSFP_1000Gp1_ASN_AF	i_dbNSFP_1000Gp1_EUR_AC	i_dbNSFP_1000Gp1_EUR_AF	i_dbNSFP_Ancestral_allele	i_dbNSFP_CADD_phred	i_dbNSFP_CADD_raw	i_dbNSFP_CADD_raw_rankscore	i_dbNSFP_ESP6500_AA_AF	i_dbNSFP_ESP6500_EA_AF	i_dbNSFP_Ensembl_geneid	i_dbNSFP_Ensembl_transcriptid	i_dbNSFP_FATHMM_pred	i_dbNSFP_FATHMM_rankscore	i_dbNSFP_FATHMM_score	i_dbNSFP_GERP_NR	i_dbNSFP_GERP_RS	i_dbNSFP_GERP_RS_rankscore	i_dbNSFP_Interpro_domain	i_dbNSFP_LRT_Omega	i_dbNSFP_LRT_converted_rankscore	i_dbNSFP_LRT_pred	i_dbNSFP_LRT_score	i_dbNSFP_LR_pred	i_dbNSFP_LR_rankscore	i_dbNSFP_LR_score	i_dbNSFP_MutationAssessor_pred	i_dbNSFP_MutationAssessor_rankscore	i_dbNSFP_MutationAssessor_score	i_dbNSFP_MutationTaster_converted_rankscore	i_dbNSFP_MutationTaster_pred	i_dbNSFP_MutationTaster_score	i_dbNSFP_Polyphen2_HDIV_pred	i_dbNSFP_Polyphen2_HDIV_rankscore	i_dbNSFP_Polyphen2_HDIV_score	i_dbNSFP_Polyphen2_HVAR_pred	i_dbNSFP_Polyphen2_HVAR_rankscore	i_dbNSFP_Polyphen2_HVAR_score	i_dbNSFP_RadialSVM_pred	i_dbNSFP_RadialSVM_rankscore	i_dbNSFP_RadialSVM_score	i_dbNSFP_Reliability_index	i_dbNSFP_SIFT_converted_rankscore	i_dbNSFP_SIFT_pred	i_dbNSFP_SIFT_score	i_dbNSFP_SLR_test_statistic	i_dbNSFP_SiPhy_29way_logOdds	i_dbNSFP_SiPhy_29way_logOdds_rankscore	i_dbNSFP_SiPhy_29way_pi	i_dbNSFP_UniSNP_ids	i_dbNSFP_Uniprot_aapos	i_dbNSFP_Uniprot_acc	i_dbNSFP_Uniprot_id	i_dbNSFP_aaalt	i_dbNSFP_aapos	i_dbNSFP_aapos_FATHMM	i_dbNSFP_aapos_SIFT	i_dbNSFP_aaref	i_dbNSFP_cds_strand	i_dbNSFP_codonpos	i_dbNSFP_folddegenerate	i_dbNSFP_genename	i_dbNSFP_hg18_pos1coor	i_dbNSFP_phastCons100way_vertebrate	i_dbNSFP_phastCons100way_vertebrate_rankscore	i_dbNSFP_phastCons46way_placental	i_dbNSFP_phastCons46way_placental_rankscore	i_dbNSFP_phastCons46way_primate	i_dbNSFP_phastCons46way_primate_rankscore	i_dbNSFP_phyloP100way_vertebrate	i_dbNSFP_phyloP100way_vertebrate_rankscore	i_dbNSFP_phyloP46way_placental	i_dbNSFP_phyloP46way_placental_rankscore	i_dbNSFP_phyloP46way_primate	i_dbNSFP_phyloP46way_primate_rankscore	i_dbNSFP_refcodon	i_gencode_transcript_name	i_gencode_transcript_status	i_gencode_transcript_tags	i_gencode_transcript_type	i_gene_id	i_gene_type	i_havana_transcript	i_init_t_lod	i_judgement	i_secondary_variant_classification	i_strand	i_t_lod_fstar	i_tumor_f	t_alt_count	t_ref_count	validation_alt_allele	validation_method	validation_status	validation_tumor_sample	validation_judgement_rna	validation_power_rna	validation_tumor_alt_count_rna	validation_tumor_ref_count_rna	validation_normal_alt_count_rna	validation_normal_ref_count_rna	discovery_tumor_alt_count_rna	discovery_tumor_ref_count_rna	discovery_normal_alt_count_rna	discovery_normal_ref_count_rna	min_val_count_rna	validation_judgement_targeted	validation_power_targeted	validation_tumor_alt_count_targeted	validation_tumor_ref_count_targeted	validation_normal_alt_count_targeted	validation_normal_ref_count_targeted	discovery_tumor_alt_count_targeted	discovery_tumor_ref_count_targeted	discovery_normal_alt_count_targeted	discovery_normal_ref_count_targeted	min_val_count_targeted	validation_status_consensus
MRTO4	51154	broad.mit.edu	37	1	19584462	19584462	+	Silent	SNP	C	C	T			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr1:19584462C>T	ENST00000330263.4	+	6	774	c.477C>T	c.(475-477)ccC>ccT	p.P159P		NM_016183.3	NP_057267.2	Q9UKD2	MRT4_HUMAN	mRNA turnover 4 homolog (S. cerevisiae)	159		NA			ribosome biogenesis	nuclear membrane|nucleolus				breast(1)|endometrium(1)|large_intestine(1)|liver(2)|ovary(1)|pancreas(1)|stomach(1)	8		Colorectal(325;3.46e-05)|Renal(390;0.000147)|all_lung(284;0.000321)|Lung NSC(340;0.000398)|Breast(348;0.00049)|Ovarian(437;0.00764)|Myeloproliferative disorder(586;0.0255)		UCEC - Uterine corpus endometrioid carcinoma (279;0.00462)|BRCA - Breast invasive adenocarcinoma(304;1.87e-05)|Kidney(64;0.000171)|KIRC - Kidney renal clear cell carcinoma(64;0.00258)|GBM - Glioblastoma multiforme(114;0.00301)|STAD - Stomach adenocarcinoma(196;0.00644)|READ - Rectum adenocarcinoma(331;0.0649)		TGGGCCTGCCCACCGCCCTCA	0.607	NA	NA					NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		GBM(192;2418 3032 7540 48714)							NA		NA		0							NA						34	39	37	NA		NA	NA	1		NA											NA				19584462		2203	4299	6502	SO:0001819	synonymous_variant			ENSG00000053372	HGNC:18477	NM_016183	Approved	uc001bbs.3	NA	B3KNB3|Q5TG55|Q96SS6|Q9BPV9	ENST00000330263.4	37	CCDS191.1																																																																																			MRTO4-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000007075.2	44.477131	KEEP		+	55.32917	0.190083	23	98	---	---	---	---	1	1	56	66	0	86	33	111	0	86	2	0	0	0	0	0	0	33	111	0	86	2	TP
GPSM2	29899	broad.mit.edu	37	1	109472462	109472462	+	Missense_Mutation	SNP	G	G	C			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr1:109472462G>C	ENST00000406462.1	+	16	2728	c.1955G>C	c.(1954-1956)aGa>aCa	p.R652T	CLCC1_ENST00000482889.1_5'Flank|CLCC1_ENST00000356970.2_3'UTR|CLCC1_ENST00000415331.1_3'UTR|CLCC1_ENST00000369969.2_3'UTR|CLCC1_ENST00000369971.2_3'UTR|CLCC1_ENST00000369968.2_3'UTR|AKNAD1_ENST00000357393.4_Intron|GPSM2_ENST00000264126.3_Missense_Mutation_p.R652T			P81274	GPSM2_HUMAN	G-protein signaling modulator 2	652		NA			G-protein coupled receptor protein signaling pathway	cell cortex|nucleus	GTPase activator activity|identical protein binding			breast(2)|central_nervous_system(1)|endometrium(1)|kidney(1)|large_intestine(4)|liver(2)|lung(3)	14		all_epithelial(167;7.64e-05)|all_lung(203;0.000321)|Lung NSC(277;0.000626)		Colorectal(144;0.0353)|Lung(183;0.0984)|COAD - Colon adenocarcinoma(174;0.129)|Epithelial(280;0.175)|all cancers(265;0.209)		CTTTTACAAAGAGATCAAAAC	0.398	NA	NA					NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA						88	87	87	NA		NA	NA	1		NA											NA				109472462		2203	4300	6503	SO:0001583	missense			ENSG00000121957	HGNC:29501	NM_013296	Approved	uc010ovc.2	NA	Q5T1N8|Q6IBL7|Q8N0Z5	ENST00000406462.1	37	CCDS792.2	.	.	.	.	.	.	.	.	.	.	G	13.75	2.331540	0.41297	.	.	ENSG00000121957	ENST00000406462;ENST00000264126	D;D	0.92911	-3.13;-3.13	5.97	5.97	0.96955	.	0.115109	0.64402	D	0.000020	T	0.75903	0.3913	N	0.08118	0	0.80722	D	1	P	0.45126	0.851	B	0.37550	0.253	T	0.79801	-0.1650	10	0.14656	T	0.56	-21.6606	19.1953	0.93686	0.0:0.0:1.0:0.0	.	652	P81274	GPSM2_HUMAN	T	652	ENSP00000385510:R652T;ENSP00000264126:R652T	ENSP00000264126:R652T	R	+	2	0	GPSM2	109273985	0.963000	0.33076	1.000000	0.80357	0.996000	0.88848	1.239000	0.32719	2.828000	0.97474	0.655000	0.94253	AGA	GPSM2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000032400.2	104.947748	KEEP		+	114.525581	0.234899	35	114	---	---	---	---	1	0.9999934	30	30	0	124	40	120	0	124	2	0	0	0	0	0	0	40	120	0	124	2	TP
PDE4DIP	9659	broad.mit.edu	37	1	144886204	144886204	+	Silent	SNP	C	C	T			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr1:144886204C>T	ENST00000369359.4	-	26	3479	c.3441G>A	c.(3439-3441)agG>agA	p.R1147R	PDE4DIP_ENST00000369354.3_Silent_p.R1010R|PDE4DIP_ENST00000369356.4_Silent_p.R1010R|PDE4DIP_ENST00000313382.9_Silent_p.R1076R|PDE4DIP_ENST00000524974.1_5'UTR|PDE4DIP_ENST00000530740.1_Silent_p.R1147R			Q5VU43	MYOME_HUMAN	phosphodiesterase 4D interacting protein	1010		NA			cellular protein complex assembly	centrosome|Golgi apparatus|myofibril|nucleus	enzyme binding	p.R1010S(2)|p.R1010N(2)		NS(1)|breast(3)|central_nervous_system(2)|cervix(2)|endometrium(15)|haematopoietic_and_lymphoid_tissue(2)|kidney(9)|large_intestine(12)|lung(106)|ovary(8)|prostate(7)|skin(3)|upper_aerodigestive_tract(4)|urinary_tract(2)	176				Colorectal(2;0.0829)|COAD - Colon adenocarcinoma(2;0.126)		GGAACTCAGCCCTCAGGTGGA	0.522	NA	NA	T	PDGFRB	MPD		NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA				Dom	yes		1	1q12	9659	phosphodiesterase 4D interacting protein (myomegalin)	NA	L	4	Substitution - Missense(4)	lung(4)					NA						210	204	206	NA		NA	NA	1		NA											NA				144886204		2203	4296	6499	SO:0001819	synonymous_variant			ENSG00000178104	HGNC:15580	NM_022359	Approved	uc021ouh.1	NA	A2RU15|O75042|O75065|Q2YDC1|Q5VU42|Q5VU44|Q5VU45|Q5VU46|Q5VU47|Q5VU48|Q5VU49|Q68DU2|Q6AZ93|Q6PK88|Q86T40|Q86TB2|Q8N3W0|Q8TAY9|Q9HCP2|Q9HCP3|Q9HCP4|Q9HCP5	ENST00000369359.4	37																																																																																				PDE4DIP-037	NOVEL	not_organism_supported|basic	protein_coding	NA	protein_coding	OTTHUMT00000384689.1	68.021326	KEEP		-	120.494507	0.12234	46	330	---	---	---	---	1	0.4780459	5	7	0	277	51	341	0	277	2	0	0	0	0	0	0	51	341	0	277	2	TP
ADAR	103	broad.mit.edu	37	1	154557202	154557202	+	3'UTR	SNP	C	C	T			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr1:154557202C>T	ENST00000368474.4	-	0	3960				ADAR_ENST00000292205.5_3'UTR|ADAR_ENST00000368471.3_3'UTR	NM_001111.4|NM_015840.3|NM_015841.3	NP_001102.2|NP_056655.2|NP_056656.2	P55265	DSRAD_HUMAN	adenosine deaminase, RNA-specific	NA		NA			adenosine to inosine editing|gene silencing by RNA|mRNA modification|mRNA processing|type I interferon-mediated signaling pathway	cytoplasm|nucleolus|nucleoplasm	DNA binding|double-stranded RNA adenosine deaminase activity|metal ion binding			NS(1)|breast(2)|central_nervous_system(1)|endometrium(4)|haematopoietic_and_lymphoid_tissue(1)|kidney(5)|large_intestine(9)|lung(20)|ovary(4)|prostate(2)|skin(2)	51	all_lung(78;2.22e-29)|Lung NSC(65;3.66e-27)|all_hematologic(923;0.088)|Hepatocellular(266;0.0997)		LUSC - Lung squamous cell carcinoma(543;0.185)	Colorectal(1306;0.115)		AATCCCCTGACCATGTGATGA	0.403	NA	NA					NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA						NA	NA	NA	NA		NA	NA			NA											NA				NA		NA	NA	NA	SO:0001624	3_prime_UTR_variant			ENSG00000160710	HGNC:225	NM_001111	Approved	uc001ffh.3	NA	B1AQQ9|B1AQR0|D3DV76|O15223|O43859|O43860|Q9BYM3|Q9BYM4	ENST00000368474.4	37	CCDS1071.1																																																																																			ADAR-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000090691.2	99.638087	KEEP		-	110.662263	0.240223	43	136	---	---	---	---	1	1	106	139	0	137	43	138	0	137	2	0	0	0	0	0	0	43	138	0	137	2	TP
LRP1B	53353	broad.mit.edu	37	2	141081530	141081530	+	Missense_Mutation	SNP	T	T	C			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr2:141081530T>C	ENST00000389484.3	-	81	13417	c.12446A>G	c.(12445-12447)gAg>gGg	p.E4149G		NM_018557.2	NP_061027.2	Q9NZR2	LRP1B_HUMAN	low density lipoprotein receptor-related protein 1B	4149		NA			protein transport|receptor-mediated endocytosis	integral to membrane	calcium ion binding			NS(5)|autonomic_ganglia(1)|biliary_tract(1)|breast(3)|central_nervous_system(7)|endometrium(25)|haematopoietic_and_lymphoid_tissue(10)|kidney(27)|large_intestine(98)|liver(4)|lung(337)|ovary(15)|pancreas(6)|prostate(11)|skin(30)|stomach(2)|upper_aerodigestive_tract(19)|urinary_tract(5)	606		all_cancers(3;1.1e-60)|all_epithelial(3;1.94e-59)|all_lung(3;1.09e-24)|Lung NSC(3;5.65e-24)|Esophageal squamous(3;5.41e-13)|Renal(3;0.000147)|Breast(3;0.000527)|Hepatocellular(3;0.011)|all_neural(3;0.014)|Colorectal(150;0.101)		UCEC - Uterine corpus endometrioid carcinoma (2;0.00139)|Epithelial(1;1.25e-24)|all cancers(1;8.86e-24)|OV - Ovarian serous cystadenocarcinoma(1;2.45e-12)|LUSC - Lung squamous cell carcinoma(1;2.97e-10)|Lung(1;6.05e-09)|BRCA - Breast invasive adenocarcinoma(221;0.0103)		AGCTAAGTACTCTACTGAACC	0.289	NA	NA					NA	NA		TSP Lung(27;0.18)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Colon(99;50 2074 2507 20106)							NA		NA		0							NA						64	73	70	NA		NA	NA	2		NA											NA				141081530		2202	4286	6488	SO:0001583	missense			ENSG00000168702	HGNC:6693	NM_018557	Approved	uc002tvj.1	NA	Q8WY29|Q8WY30|Q8WY31	ENST00000389484.3	37	CCDS2182.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	T|T	17.15|17.15	3.314960|3.314960	0.60524|0.60524	.|.	.|.	ENSG00000168702|ENSG00000168702	ENST00000389484;ENST00000544579|ENST00000437977	D|.	0.91068|.	-2.78|.	5.37|5.37	5.37|5.37	0.77165|0.77165	Six-bladed beta-propeller, TolB-like (1);Growth factor, receptor (1);|.	0.000000|.	0.85682|.	D|.	0.000000|.	T|T	0.74794|0.74794	0.3763|0.3763	M|M	0.74647|0.74647	2.275|2.275	0.43771|0.43771	D|D	0.996299|0.996299	B|.	0.21606|.	0.058|.	B|.	0.23419|.	0.046|.	T|T	0.75528|0.75528	-0.3286|-0.3286	10|5	0.44086|.	T|.	0.13|.	.|.	15.6612|15.6612	0.77188|0.77188	0.0:0.0:0.0:1.0|0.0:0.0:0.0:1.0	.|.	4149|.	Q9NZR2|.	LRP1B_HUMAN|.	G|G	4149;4087|381	ENSP00000374135:E4149G|.	ENSP00000374135:E4149G|.	E|S	-|-	2|1	0|0	LRP1B|LRP1B	140798000|140798000	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.973000|0.973000	0.67179|0.67179	7.636000|7.636000	0.83301|0.83301	2.164000|2.164000	0.68074|0.68074	0.533000|0.533000	0.62120|0.62120	GAG|AGT	LRP1B-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000254736.2	70.016626	KEEP		-	73.503171	0.278481	22	57	---	---	---	---	1	0.597254	3	3	0	204	27	61	0	204	2	0	0	0	0	0	0	27	61	0	204	2	TP
CHL1	10752	broad.mit.edu	37	3	405060	405060	+	Missense_Mutation	SNP	A	A	T			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr3:405060A>T	ENST00000256509.2	+	14	2221	c.1579A>T	c.(1579-1581)Att>Ttt	p.I527F	CHL1-AS1_ENST00000417612.1_RNA|CHL1_ENST00000397491.2_Missense_Mutation_p.I511F	NM_001253387.1|NM_001253388.1|NM_006614.3	NP_001240316.1|NP_001240317.1|NP_006605.2	O00533	CHL1_HUMAN	cell adhesion molecule L1-like	511	Ig-like C2-type 6.	NA			axon guidance|cell adhesion|signal transduction	integral to membrane|plasma membrane|proteinaceous extracellular matrix				NS(1)|central_nervous_system(5)|endometrium(11)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(25)|lung(31)|ovary(1)|prostate(4)|skin(10)|stomach(1)	93		all_cancers(2;1.14e-06)|all_epithelial(2;0.00367)|all_lung(1;0.061)|Lung NSC(2;0.201)		Epithelial(13;5.36e-06)|all cancers(10;1.4e-05)|OV - Ovarian serous cystadenocarcinoma(96;0.00323)|COAD - Colon adenocarcinoma(1;0.00925)|Colorectal(20;0.0198)		CAATTTGGATATTAGAAGTAT	0.378	NA	NA					NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA						104	106	106	NA		NA	NA	3		NA											NA				405060		2203	4300	6503	SO:0001583	missense			ENSG00000134121	HGNC:1939	NM_006614	Approved	uc003bot.3	NA	B7ZL03|Q2M3G2|Q59FY0	ENST00000256509.2	37	CCDS2556.1	.	.	.	.	.	.	.	.	.	.	A	19.42	3.823280	0.71143	.	.	ENSG00000134121	ENST00000256509;ENST00000397491	T;T	0.31247	1.5;1.5	5.11	3.96	0.45880	Immunoglobulin I-set (1);Immunoglobulin-like fold (1);	0.061471	0.64402	D	0.000003	T	0.55081	0.1898	M	0.86343	2.81	0.44402	D	0.997315	D;D;D	0.69078	0.997;0.997;0.982	D;D;P	0.73708	0.981;0.981;0.907	T	0.57505	-0.7800	10	0.87932	D	0	.	6.875	0.24141	0.816:0.0:0.184:0.0	.	511;511;527	B3KX75;O00533;O00533-2	.;CHL1_HUMAN;.	F	527;511	ENSP00000256509:I527F;ENSP00000380628:I511F	ENSP00000256509:I527F	I	+	1	0	CHL1	380060	1.000000	0.71417	0.990000	0.47175	0.998000	0.95712	2.344000	0.44010	0.888000	0.36160	0.528000	0.53228	ATT	CHL1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000207155.2	77.919139	KEEP		+	85.401338	0.239669	29	92	---	---	---	---	1	0.9695438	6	14	0	145	35	106	0	145	2	0	0	0	0	0	0	35	106	0	145	2	TP
BAP1	8314	broad.mit.edu	37	3	52443911	52443911	+	5'UTR	SNP	C	C	T			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr3:52443911C>T	ENST00000460680.1	-	0	455				BAP1_ENST00000296288.5_5'UTR|PHF7_ENST00000347025.2_5'Flank|PHF7_ENST00000327906.3_5'Flank|PHF7_ENST00000478707.1_5'Flank	NM_004656.2	NP_004647.1	Q92560	BAP1_HUMAN	BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)	NA		NA			monoubiquitinated histone H2A deubiquitination|negative regulation of cell proliferation|protein K48-linked deubiquitination|regulation of cell cycle|regulation of cell growth|ubiquitin-dependent protein catabolic process	cytoplasm|nucleolus|PR-DUB complex	chromatin binding|protein binding|ubiquitin thiolesterase activity|ubiquitin-specific protease activity			NS(1)|breast(4)|endometrium(3)|eye(42)|kidney(60)|large_intestine(3)|lung(9)|ovary(4)|pleura(39)|prostate(4)|skin(9)|urinary_tract(2)	180				BRCA - Breast invasive adenocarcinoma(193;1.72e-05)|Kidney(197;0.0018)|KIRC - Kidney renal clear cell carcinoma(197;0.00203)|OV - Ovarian serous cystadenocarcinoma(275;0.0277)		GCGGGGCGGCCCCTCAGCGCC	0.751	NA	NA	"""N, Mis, F, S, O"""		"""uveal melanoma, breast, NSCLC, RCC"""	"""mesothelioma, uveal melanoma"""	NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		GBM(101;493 1458 7992 21037 25532)		Rec	yes		3	3p21.31-p21.2	8314	BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)	NA	E	0							NA						21	26	24	NA		NA	NA	3		NA											NA				52443911		2200	4298	6498	SO:0001623	5_prime_UTR_variant			ENSG00000163930	HGNC:950		Approved	uc003ddx.4	NA	A8K993|Q6LEM0|Q7Z5E8	ENST00000460680.1	37	CCDS2853.1																																																																																			BAP1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000350895.1	15.516534	KEEP		-	21.206201	0.156863	8	43	---	---	---	---	1	0.9780249	16	22	0	48	12	64	0	48	2	0	0	0	0	0	0	12	64	0	48	2	TP
PIK3CB	5291	broad.mit.edu	37	3	138417859	138417859	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr3:138417859C>T	ENST00000477593.1	-	12	1733	c.1660G>A	c.(1660-1662)Gaa>Aaa	p.E554K	PIK3CB_ENST00000544716.1_5'UTR|PIK3CB_ENST00000289153.2_Missense_Mutation_p.E554K			P42338	PK3CB_HUMAN	phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit beta	554	PI3K helical.	NA			activation of MAPK activity|chemotaxis|fibroblast growth factor receptor signaling pathway|G-protein coupled receptor protein signaling pathway|insulin receptor signaling pathway|leukocyte migration|nerve growth factor receptor signaling pathway|phosphatidylinositol-mediated signaling|platelet activation|T cell receptor signaling pathway	phosphatidylinositol 3-kinase complex	1-phosphatidylinositol-3-kinase activity|ATP binding|phosphatidylinositol-4,5-bisphosphate 3-kinase activity			NS(1)|breast(3)|endometrium(5)|kidney(2)|large_intestine(4)|lung(17)|ovary(1)|skin(3)|upper_aerodigestive_tract(1)|urinary_tract(4)	41						AGATCCATTTCATTTTCACAC	0.383	NA	NA					NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA						104	103	103	NA		NA	NA	3		NA											NA				138417859		2203	4300	6503	SO:0001583	missense			ENSG00000051382	HGNC:8976		Approved	uc011bmq.3	NA	D3DNF0|Q24JU2	ENST00000477593.1	37	CCDS3104.1	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	C|C	32|32	5.171296|5.171296	0.94807|0.94807	.|.	.|.	ENSG00000051382|ENSG00000051382	ENST00000477593;ENST00000289153|ENST00000493568	T;T|.	0.69435|.	-0.4;-0.4|.	5.91|5.91	5.04|5.04	0.67666|0.67666	Phosphoinositide 3-kinase, accessory (PIK) domain (3);Armadillo-type fold (1);|.	0.095718|.	0.64402|.	D|.	0.000001|.	T|T	0.73976|0.73976	0.3656|0.3656	M|M	0.75085|0.75085	2.285|2.285	0.80722|0.80722	D|D	1|1	P;P|.	0.48407|.	0.91;0.833|.	P;P|.	0.58391|.	0.838;0.6|.	T|T	0.74890|0.74890	-0.3510|-0.3510	10|5	0.46703|.	T|.	0.11|.	-22.153|-22.153	14.825|14.825	0.70104|0.70104	0.0:0.9315:0.0:0.0685|0.0:0.9315:0.0:0.0685	.|.	554;141|.	P42338;B4DZI3|.	PK3CB_HUMAN;.|.	K|I	554|185	ENSP00000418143:E554K;ENSP00000289153:E554K|.	ENSP00000289153:E554K|.	E|M	-|-	1|3	0|0	PIK3CB|PIK3CB	139900549|139900549	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.991000|0.991000	0.79684|0.79684	7.487000|7.487000	0.81328|0.81328	1.513000|1.513000	0.48852|0.48852	0.460000|0.460000	0.39030|0.39030	GAA|ATG	PIK3CB-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000358019.1	131.214781	KEEP		-	138.414054	0.288889	52	128	---	---	---	---	1	0.9986029	7	20	0	141	57	134	0	141	2	0	0	0	0	0	0	57	134	0	141	2	TP
SPARCL1	8404	broad.mit.edu	37	4	88420673	88420673	+	Splice_Site	SNP	C	C	T			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr4:88420673C>T	ENST00000418378.1	-	3	625	c.54_splice	c.e3+1	p.P18_splice	SPARCL1_ENST00000503414.1_5'UTR|SPARCL1_ENST00000282470.6_Splice_Site_p.P18_splice	NM_001128310.1	NP_001121782.1	Q14515	SPRL1_HUMAN	SPARC-like 1 (hevin)	18		NA			signal transduction	extracellular space|proteinaceous extracellular matrix	calcium ion binding			breast(1)|endometrium(2)|kidney(1)|large_intestine(5)|lung(7)|ovary(1)|skin(2)|stomach(2)	21				OV - Ovarian serous cystadenocarcinoma(123;0.00118)		GGAAATTTACCGGGATTGCAG	0.363	NA	NA					NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA						97	105	102	NA		NA	NA	4		NA											NA				88420673		2203	4300	6503	SO:0001630	splice_region_variant			ENSG00000152583	HGNC:11220		Approved	uc003hqs.4	NA	Q14800	ENST00000418378.1	37	CCDS3622.1																																																																																			SPARCL1-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding		-25.126283	KEEP	Silent	-	6.458258	0.030769	4	126	---	---	---	---	1	0.9999998	2	4196	0	159	4	142	0	159	2	0	0	0	0	0	0	4	142	0	159	2	TP
FGA	2243	broad.mit.edu	37	4	155507297	155507297	+	Nonsense_Mutation	SNP	G	G	T			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr4:155507297G>T	ENST00000302053.3	-	5	1362	c.1284C>A	c.(1282-1284)taC>taA	p.Y428*	FGA_ENST00000403106.3_Nonsense_Mutation_p.Y428*	NM_000508.3	NP_000499.1	P02671	FIBA_HUMAN	fibrinogen alpha chain	428		NA			platelet activation|platelet degranulation|protein polymerization|response to calcium ion|signal transduction	external side of plasma membrane|fibrinogen complex|platelet alpha granule lumen	eukaryotic cell surface binding|protein binding, bridging|receptor binding			NS(1)|breast(5)|central_nervous_system(2)|cervix(1)|endometrium(6)|kidney(2)|large_intestine(14)|liver(2)|lung(20)|ovary(3)|pancreas(1)|prostate(8)|skin(1)|upper_aerodigestive_tract(1)|urinary_tract(6)	73	all_hematologic(180;0.215)	Renal(120;0.0458)			Alteplase(DB00009)|Anistreplase(DB00029)|Reteplase(DB00015)|Sucralfate(DB00364)|Tenecteplase(DB00031)	TTTCTGTGTGGTACTCTCTCC	0.512	NA	NA					NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NSCLC(143;340 1922 20892 22370 48145)							NA		NA		0							NA						184	190	188	NA		NA	NA	4		NA											NA				155507297		2203	4300	6503	SO:0001587	stop_gained			ENSG00000171560	HGNC:3661	NM_000508	Approved	uc003iod.1	NA	D3DP14|D3DP15|Q4QQH7|Q9BX62|Q9UCH2	ENST00000302053.3	37	CCDS3787.1	.	.	.	.	.	.	.	.	.	.	G	20.3	3.961218	0.74016	.	.	ENSG00000171560	ENST00000302053;ENST00000403106	.	.	.	5.89	2.19	0.27852	.	54.872900	0.00166	N	0.000004	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	0.02654	T	1	.	5.9346	0.19158	0.2182:0.1401:0.6418:0.0	.	.	.	.	X	428	.	ENSP00000306361:Y428X	Y	-	3	2	FGA	155726747	0.577000	0.26708	0.007000	0.13788	0.404000	0.30871	0.582000	0.23834	0.096000	0.17463	0.655000	0.94253	TAC	FGA-002	KNOWN	not_organism_supported|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000317593.1	251.362021	KEEP		-	283.522109	0.223195	102	355	---	---	---	---	0	0	0	0	0	369	108	382	0	369	2	1	1	184	558	1	684	108	382	0	369	6	TP
THBS4	7060	broad.mit.edu	37	5	79378941	79378941	+	Missense_Mutation	SNP	A	A	G			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr5:79378941A>G	ENST00000350881.2	+	22	3053	c.2863A>G	c.(2863-2865)Aat>Gat	p.N955D	CTD-2201I18.1_ENST00000503007.1_RNA|CTD-2201I18.1_ENST00000514042.1_RNA|THBS4_ENST00000504720.1_3'UTR|THBS4_ENST00000511733.1_Missense_Mutation_p.N864D	NM_003248.4	NP_003239.2	P35443	TSP4_HUMAN	thrombospondin 4	955		NA			endothelial cell-cell adhesion|myoblast migration|negative regulation of angiogenesis|positive regulation of endothelial cell proliferation|positive regulation of neutrophil chemotaxis|positive regulation of peptidyl-tyrosine phosphorylation	basement membrane|extracellular space	calcium ion binding|heparin binding|integrin binding|structural molecule activity			breast(1)|endometrium(4)|kidney(2)|large_intestine(9)|lung(14)|ovary(1)|stomach(3)	34		Lung NSC(167;0.00328)|all_lung(232;0.00355)|Ovarian(174;0.0261)		OV - Ovarian serous cystadenocarcinoma(54;6.3e-45)|Epithelial(54;1.77e-39)|all cancers(79;3.2e-34)		TCAAACCCAGAATTTCGACCG	0.453	NA	NA					NA	NA			OREG0016685	type=REGULATORY REGION|TFbs=CTCF|Dataset=CTCF ChIP-chip sites (Ren lab)|EvidenceSubtype=ChIP-on-chip (ChIP-chip)		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA						90	99	96	NA		NA	NA	5		NA											NA				79378941		2203	4300	6503	SO:0001583	missense			ENSG00000113296	HGNC:11788		Approved	uc021yaw.1	1190	B2R909|Q86TG2	ENST00000350881.2	37	CCDS4049.1	.	.	.	.	.	.	.	.	.	.	A	17.31	3.356531	0.61293	.	.	ENSG00000113296	ENST00000350881;ENST00000511733	D;D	0.86164	-1.95;-2.08	5.91	0.22	0.15279	.	0.360182	0.34652	N	0.003798	T	0.76630	0.4014	L	0.32530	0.975	0.25020	N	0.991348	B	0.02656	0.0	B	0.01281	0.0	T	0.58951	-0.7545	10	0.18276	T	0.48	-7.5648	10.4245	0.44369	0.3282:0.5972:0.0746:0.0	.	955	P35443	TSP4_HUMAN	D	955;864	ENSP00000339730:N955D;ENSP00000422298:N864D	ENSP00000339730:N955D	N	+	1	0	THBS4	79414697	1.000000	0.71417	0.993000	0.49108	0.995000	0.86356	1.972000	0.40540	0.095000	0.17434	0.533000	0.62120	AAT	THBS4-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000226977.1	107.812809	KEEP		+	115.520738	0.256944	37	107	---	---	---	---	1	1	59	146	0	156	43	131	0	156	2	0	0	0	0	0	0	43	131	0	156	2	TP
HARS	3035	broad.mit.edu	37	5	140053903	140053903	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr5:140053903C>T	ENST00000504366.1	-	12	3081	c.1262G>A	c.(1261-1263)cGa>cAa	p.R421Q	HARS_ENST00000415192.2_Missense_Mutation_p.R416Q|HARS_ENST00000431330.2_Missense_Mutation_p.R376Q|HARS_ENST00000307633.3_Missense_Mutation_p.R430Q|HARS_ENST00000448240.1_Missense_Mutation_p.R295Q|HARS_ENST00000504156.1_Missense_Mutation_p.R490Q|HARS_ENST00000457527.2_Missense_Mutation_p.R470Q|HARS_ENST00000438307.2_Missense_Mutation_p.R450Q|DND1_ENST00000542735.1_5'Flank			P12081	SYHC_HUMAN	histidyl-tRNA synthetase	490		NA			histidyl-tRNA aminoacylation	cytosol	ATP binding|histidine-tRNA ligase activity			NS(1)|endometrium(1)|haematopoietic_and_lymphoid_tissue(1)|large_intestine(3)|lung(8)|ovary(1)|prostate(1)|skin(1)|upper_aerodigestive_tract(2)	19			KIRC - Kidney renal clear cell carcinoma(527;0.00112)|Kidney(363;0.00191)		L-Histidine(DB00117)	GTCTTCTCTTCGGACATCCAC	0.522	NA	NA					NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA						126	113	117	NA		NA	NA	5		NA											NA				140053903		2203	4300	6503	SO:0001583	missense			ENSG00000170445	HGNC:4816	NM_002109	Approved	uc003lgv.4	NA		ENST00000504366.1	37		.	.	.	.	.	.	.	.	.	.	C	14.24	2.476790	0.44044	.	.	ENSG00000170445	ENST00000504156;ENST00000457527;ENST00000431330;ENST00000504366;ENST00000307633;ENST00000448240;ENST00000438307;ENST00000415192	D;D;D;D;D;D;D;D	0.82255	-1.59;-1.59;-1.59;-1.59;-1.59;-1.59;-1.59;-1.59	4.93	3.1	0.35709	Anticodon-binding (3);	0.368895	0.28230	N	0.016109	T	0.73273	0.3566	L	0.49126	1.545	0.33673	D	0.611119	B;B;B;B;B;B	0.31655	0.334;0.11;0.0;0.039;0.039;0.01	B;B;B;B;B;B	0.17979	0.02;0.02;0.001;0.016;0.01;0.003	T	0.76293	-0.3012	10	0.40728	T	0.16	-2.4407	8.3997	0.32579	0.0:0.759:0.1569:0.0842	.	376;416;430;450;470;490	B4E1C5;B4DDD8;B4DHQ1;B4DY73;D6REN6;P12081	.;.;.;.;.;SYHC_HUMAN	Q	490;470;376;421;430;295;450;416	ENSP00000425634:R490Q;ENSP00000387893:R470Q;ENSP00000393244:R376Q;ENSP00000430063:R421Q;ENSP00000304668:R430Q;ENSP00000413605:R295Q;ENSP00000411511:R450Q;ENSP00000411085:R416Q	ENSP00000304668:R430Q	R	-	2	0	HARS	140034087	0.923000	0.31300	1.000000	0.80357	0.992000	0.81027	1.108000	0.31123	1.183000	0.42943	0.655000	0.94253	CGA	HARS-003	PUTATIVE	basic	protein_coding	NA	protein_coding	OTTHUMT00000372852.3	37.595872	KEEP		-	47.221216	0.18	18	82	---	---	---	---	1	1	142	199	0	90	19	90	0	90	2	0	0	0	0	0	0	19	90	0	90	2	TP
Unknown	0	broad.mit.edu	37	6	29856360	29856360	+	IGR	SNP	C	C	A			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr6:29856360C>A			NA	NA				HLA-G (57458 upstream) : HLA-A (52676 downstream)						NA		NA									NA						GAACGAGGACCTGCGCTCCTG	0.672	NA	NA					NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA						NA	NA	NA	NA		NA	NA			NA											NA				NA		NA	NA	NA	SO:0001628	intergenic_variant								NA			37																																																																																								0			57.641511	KEEP			63.107133	0.25	24	72	---	---	---	---	1	1	849	2537	0	109	30	88	0	109	2	0	0	0	0	0	0	30	88	0	109	2	TP
PRRT1	80863	broad.mit.edu	37	6	32118160	32118160	+	Silent	SNP	G	G	A			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr6:32118160G>A	ENST00000211413.5	-	2	667	c.543C>T	c.(541-543)gtC>gtT	p.V181V	PRRT1_ENST00000375150.2_Silent_p.V100V|PRRT1_ENST00000375152.2_Silent_p.V100V|PRRT1_ENST00000467780.1_5'Flank	NM_030651.3	NP_085154.3	Q99946	PRRT1_HUMAN	proline-rich transmembrane protein 1	181		NA			response to biotic stimulus	integral to membrane				breast(2)|endometrium(1)|kidney(1)|lung(2)	6						CCACCGGGTAGACCGGCACGT	0.667	NA	NA					NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA						34	35	35	NA		NA	NA	6		NA											NA				32118160		1508	2707	4215	SO:0001819	synonymous_variant				HGNC:13943	NM_030651	Approved	uc003nzt.3	NA	A6ND08|A6ND40|B0S869|Q5SSW4|Q5SSX7|Q5STI1|Q96DW3|Q96NQ8	ENST00000211413.5	37	CCDS4739.1																																																																																			PRRT1-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000076255.2	47.282897	KEEP		-	52.139348	0.240506	19	60	---	---	---	---	1	0.667093	7	3	0	83	19	70	0	83	2	0	0	0	0	0	0	19	70	0	83	2	TP
ITPR3	3710	broad.mit.edu	37	6	33633622	33633622	+	Nonsense_Mutation	SNP	C	C	T			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr6:33633622C>T	ENST00000374316.5	+	15	2480	c.1420C>T	c.(1420-1422)Cag>Tag	p.Q474*	ITPR3_ENST00000605930.1_Nonsense_Mutation_p.Q474*			Q14573	ITPR3_HUMAN	inositol 1,4,5-trisphosphate receptor, type 3	474		NA			activation of phospholipase C activity|calcium ion transport into cytosol|energy reserve metabolic process|G-protein coupled receptor protein signaling pathway|nerve growth factor receptor signaling pathway|platelet activation|protein heterooligomerization|protein homooligomerization|regulation of insulin secretion|response to calcium ion	apical part of cell|brush border|endoplasmic reticulum membrane|integral to plasma membrane|myelin sheath|neuronal cell body|nuclear outer membrane|platelet dense tubular network membrane	inositol 1,3,4,5 tetrakisphosphate binding|inositol 1,4,5 trisphosphate binding|inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity|inositol hexakisphosphate binding|intracellular ligand-gated calcium channel activity|protein binding			NS(1)|breast(6)|central_nervous_system(5)|endometrium(9)|haematopoietic_and_lymphoid_tissue(1)|kidney(3)|large_intestine(18)|liver(1)|lung(24)|ovary(8)|prostate(2)|skin(2)|upper_aerodigestive_tract(3)|urinary_tract(2)	85						GTTTGTCATCCAGCTGCTGGA	0.572	NA	NA					NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA						137	103	114	NA		NA	NA	6		NA											NA				33633622		2203	4300	6503	SO:0001587	stop_gained			ENSG00000096433	HGNC:6182	NM_002224	Approved	uc021ywr.1	NA	Q14649|Q5TAQ2	ENST00000374316.5	37	CCDS4783.1	.	.	.	.	.	.	.	.	.	.	C	46	12.684424	0.99688	.	.	ENSG00000096433	ENST00000374316	.	.	.	5.4	5.4	0.78164	.	0.058885	0.64402	D	0.000002	.	.	.	.	.	.	0.80722	A	1	.	.	.	.	.	.	.	.	.	.	0.02654	T	1	-31.2065	14.0635	0.64815	0.1507:0.8493:0.0:0.0	.	.	.	.	X	474	.	ENSP00000363435:Q474X	Q	+	1	0	ITPR3	33741600	1.000000	0.71417	1.000000	0.80357	0.818000	0.46254	6.378000	0.73150	2.539000	0.85634	0.563000	0.77884	CAG	ITPR3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000040204.2	60.644059	KEEP		+	67.002176	0.237624	24	77	---	---	---	---	1	0.6536978	3	6	0	82	27	90	0	82	2	0	0	0	0	0	0	27	90	0	82	2	TP
VEGFA	7422	broad.mit.edu	37	6	43748479	43748479	+	Nonsense_Mutation	SNP	C	C	T	rs45533131		GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr6:43748479C>T	ENST00000425836.2	+	6	973	c.973C>T	c.(973-975)Cga>Tga	p.R325*	VEGFA_ENST00000413642.3_Nonsense_Mutation_p.R325*|VEGFA_ENST00000372067.3_Intron|VEGFA_ENST00000520948.1_Nonsense_Mutation_p.R145*|VEGFA_ENST00000417285.2_Intron|VEGFA_ENST00000457104.2_Intron|VEGFA_ENST00000518824.1_Intron|VEGFA_ENST00000523125.1_Intron|VEGFA_ENST00000372064.4_Intron|VEGFA_ENST00000324450.6_Intron|VEGFA_ENST00000523873.1_Nonsense_Mutation_p.R145*|VEGFA_ENST00000372077.4_Intron|VEGFA_ENST00000482630.2_Intron|VEGFA_ENST00000372055.4_Nonsense_Mutation_p.R325*|VEGFA_ENST00000523950.1_Intron|VEGFA_ENST00000230480.6_Intron|VEGFA_ENST00000518689.1_Nonsense_Mutation_p.R145*			P15692	VEGFA_HUMAN	vascular endothelial growth factor A	145		NA			basophil chemotaxis|cellular response to hypoxia|induction of positive chemotaxis|platelet activation|platelet degranulation|platelet-derived growth factor receptor signaling pathway|positive regulation of angiogenesis|positive regulation of blood vessel endothelial cell migration|positive regulation of cell adhesion|positive regulation of cell division|positive regulation of endothelial cell proliferation|positive regulation of leukocyte migration|positive regulation of mast cell chemotaxis|positive regulation of peptidyl-tyrosine phosphorylation|positive regulation of vascular endothelial growth factor receptor signaling pathway|positive regulation of vascular permeability|regulation of cell shape|vascular endothelial growth factor receptor signaling pathway|vasculogenesis	cell surface|extracellular space|membrane|platelet alpha granule lumen	cell surface binding|chemoattractant activity|cytokine activity|fibronectin binding|growth factor activity|heparin binding|platelet-derived growth factor receptor binding|protein heterodimerization activity|protein homodimerization activity|vascular endothelial growth factor receptor 1 binding|vascular endothelial growth factor receptor 2 binding|vascular endothelial growth factor receptor binding	p.R325*(1)		breast(1)|endometrium(2)|kidney(1)|large_intestine(2)|lung(1)|ovary(1)|prostate(1)	9	all_cancers(18;5.46e-07)|all_epithelial(2;5.96e-08)|Lung NSC(15;0.000157)|all_lung(25;0.000486)|Hepatocellular(11;0.00309)		all cancers(41;0.000413)|Colorectal(64;0.00245)|COAD - Colon adenocarcinoma(64;0.00536)|STAD - Stomach adenocarcinoma(11;0.0742)|OV - Ovarian serous cystadenocarcinoma(102;0.196)		Atorvastatin(DB01076)|Bevacizumab(DB00112)|Carvedilol(DB01136)|Ginkgo biloba(DB01381)|Gliclazide(DB01120)|Minocycline(DB01017)|Ranibizumab(DB01270)|Simvastatin(DB00641)	AAAATCAGTTCGAGGAAAGGG	0.532	NA	NA					NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		1	Substitution - Nonsense(1)	prostate(1)					NA						89	90	90	NA		NA	NA	6		NA											NA				43748479		2203	4300	6503	SO:0001587	stop_gained			ENSG00000112715	HGNC:12680	NM_001025366	Approved	uc003owh.3	NA	B5BU86|O60720|O75875|Q074Z4|Q16889|Q5UB46|Q6P0P5|Q96KJ0|Q96L82|Q96NW5|Q9H1W8|Q9H1W9|Q9UH58|Q9UL23	ENST00000425836.2	37	CCDS4907.2	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	.|.	C|C	37|37	6.542237|6.542237	0.97650|0.97650	.|.	.|.	ENSG00000112715|ENSG00000112715	ENST00000413642;ENST00000372055;ENST00000425836;ENST00000520948;ENST00000523873;ENST00000518689|ENST00000519767	.|.	.|.	.|.	4.85|4.85	4.85|4.85	0.62838|0.62838	.|.	4.362100|.	0.00520|.	N|.	0.000187|.	.|T	.|0.66886	.|0.2835	.|.	.|.	.|.	0.80722|0.80722	D|D	1|1	.|.	.|.	.|.	.|.	.|.	.|.	.|T	.|0.66384	.|-0.5937	.|4	0.02654|.	T|.	1|.	-0.4131|-0.4131	17.3086|17.3086	0.87202|0.87202	0.0:1.0:0.0:0.0|0.0:1.0:0.0:0.0	rs45533131|rs45533131	.|.	.|.	.|.	X|L	325;325;325;145;145;145|296	.|.	ENSP00000361125:R325X|.	R|S	+|+	1|2	2|0	VEGFA|VEGFA	43856457|43856457	1.000000|1.000000	0.71417|0.71417	1.000000|1.000000	0.80357|0.80357	0.995000|0.995000	0.86356|0.86356	2.970000|2.970000	0.49240|0.49240	2.387000|2.387000	0.81309|0.81309	0.561000|0.561000	0.74099|0.74099	CGA|TCG	VEGFA-003	KNOWN	non_ATG_start|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000259260.4	105.442769	KEEP		+	116.281954	0.241573	43	135	---	---	---	---	1	1	1847	292	1	144	46	145	1	144	54	0	0	0	0	0	0	46	145	1	144	2	TP
EGFR	1956	broad.mit.edu	37	7	55238870	55238870	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr7:55238870G>A	ENST00000275493.2	+	16	2060	c.1883G>A	c.(1882-1884)tGc>tAc	p.C628Y	EGFR_ENST00000455089.1_Missense_Mutation_p.C583Y|EGFR_ENST00000454757.2_Missense_Mutation_p.C575Y|EGFR_ENST00000442591.1_Missense_Mutation_p.C628Y	NM_005228.3	NP_005219.2	P00533	EGFR_HUMAN	epidermal growth factor receptor	628		NA			activation of phospholipase A2 activity by calcium-mediated signaling|activation of phospholipase C activity|axon guidance|cell proliferation|cell-cell adhesion|negative regulation of apoptosis|negative regulation of epidermal growth factor receptor signaling pathway|ossification|positive regulation of catenin import into nucleus|positive regulation of cell migration|positive regulation of cyclin-dependent protein kinase activity involved in G1/S|positive regulation of epithelial cell proliferation|positive regulation of MAP kinase activity|positive regulation of nitric oxide biosynthetic process|positive regulation of phosphorylation|positive regulation of protein kinase B signaling cascade|protein autophosphorylation|protein insertion into membrane|regulation of nitric-oxide synthase activity|regulation of peptidyl-tyrosine phosphorylation|response to stress|response to UV-A	basolateral plasma membrane|endoplasmic reticulum membrane|endosome|extracellular space|Golgi membrane|integral to membrane|nuclear membrane|Shc-EGFR complex	actin filament binding|ATP binding|double-stranded DNA binding|epidermal growth factor receptor activity|identical protein binding|MAP/ERK kinase kinase activity|protein heterodimerization activity|protein phosphatase binding|receptor signaling protein tyrosine kinase activity			NS(2)|adrenal_gland(5)|biliary_tract(8)|bone(3)|breast(18)|central_nervous_system(106)|endometrium(26)|eye(3)|haematopoietic_and_lymphoid_tissue(9)|kidney(11)|large_intestine(85)|liver(2)|lung(13575)|oesophagus(21)|ovary(38)|pancreas(3)|peritoneum(11)|pleura(2)|prostate(35)|salivary_gland(11)|skin(9)|small_intestine(1)|soft_tissue(4)|stomach(41)|thymus(2)|thyroid(14)|upper_aerodigestive_tract(59)|urinary_tract(6)	14110	all_cancers(1;1.57e-46)|all_epithelial(1;5.62e-37)|Lung NSC(1;9.29e-25)|all_lung(1;4.39e-23)|Esophageal squamous(2;7.55e-08)|Breast(14;0.0318)		GBM - Glioblastoma multiforme(1;0)|all cancers(1;2.19e-314)|Lung(13;4.65e-05)|LUSC - Lung squamous cell carcinoma(13;0.000168)|STAD - Stomach adenocarcinoma(5;0.00164)|Epithelial(13;0.0607)		Cetuximab(DB00002)|Erlotinib(DB00530)|Gefitinib(DB00317)|Lapatinib(DB01259)|Lidocaine(DB00281)|Panitumumab(DB01269)|Trastuzumab(DB00072)	TCCTACAGATGCACTGGGCCA	0.393	NA	8	"""A, O, Mis"""		"""glioma, NSCLC"""	NSCLC	NA	NA	Lung Cancer, Familial Clustering of	TCGA GBM(3;<1E-08)|TSP Lung(4;<1E-08)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			yes	Dom	yes	Familial lung cancer	7	7p12.3-p12.1	1956	"""epidermal growth factor receptor (erythroblastic leukemia viral (v-erb-b) oncogene homolog, avian)"""	NA	"""E, O"""	0							NA						134	119	124	NA		NA	NA	7		NA											NA				55238870		2203	4300	6503	SO:0001583	missense	Familial Cancer Database	incl. Hereditary Lung cancer, Hereditary Non-Small Cell Lung cancer	ENSG00000146648	HGNC:3236	NM_005228	Approved	uc003tqk.3	NA	O00688|O00732|P06268|Q14225|Q68GS5|Q92795|Q9BZS2|Q9GZX1|Q9H2C9|Q9H3C9|Q9UMD7|Q9UMD8|Q9UMG5	ENST00000275493.2	37	CCDS5514.1	.	.	.	.	.	.	.	.	.	.	G	16.25	3.070678	0.55539	.	.	ENSG00000146648	ENST00000455089;ENST00000395504;ENST00000275493;ENST00000442591;ENST00000454757;ENST00000533450	T;T;T;T	0.56444	0.46;0.46;0.46;0.46	5.54	5.54	0.83059	Growth factor, receptor (1);	0.087063	0.85682	D	0.000000	T	0.82245	0.4995	H	0.97635	4.045	0.80722	D	1	D;D	0.76494	0.989;0.999	P;D	0.73708	0.765;0.981	D	0.88094	0.2815	10	0.87932	D	0	.	16.5484	0.84457	0.0:0.0:1.0:0.0	.	583;628	Q504U8;P00533	.;EGFR_HUMAN	Y	583;498;628;628;575;422	ENSP00000415559:C583Y;ENSP00000275493:C628Y;ENSP00000410031:C628Y;ENSP00000395243:C575Y	ENSP00000275493:C628Y	C	+	2	0	EGFR	55206364	1.000000	0.71417	0.970000	0.41538	0.066000	0.16364	7.285000	0.78660	2.768000	0.95171	0.561000	0.74099	TGC	EGFR-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000251456.2	31.362105	KEEP		+	178.032538	0.094595	84	804	---	---	---	---	1	1	152	382	0	128	96	925	0	128	2	1	1	140	1270	5	1355	96	925	0	128	16	TP
AZGP1	563	broad.mit.edu	37	7	99569626	99569626	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr7:99569626C>T	ENST00000411734.1	-	2	76	c.71G>A	c.(70-72)cGt>cAt	p.R24H	AZGP1_ENST00000292401.4_Missense_Mutation_p.R27H			P25311	ZA2G_HUMAN	alpha-2-glycoprotein 1, zinc-binding	27		NA			antigen processing and presentation|cell adhesion|immune response|lipid catabolic process|negative regulation of cell proliferation	extracellular region|MHC class I protein complex	fatty acid binding|protein transmembrane transporter activity|ribonuclease activity			central_nervous_system(1)|endometrium(2)|kidney(1)|large_intestine(3)|lung(6)|ovary(1)|prostate(1)|stomach(1)	16	Esophageal squamous(72;0.0166)|Lung NSC(181;0.0211)|all_lung(186;0.0323)					CAGAGAGTAACGACCTGCAAA	0.527	NA	NA					NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA						59	58	58	NA		NA	NA	7		NA											NA				99569626		2203	4300	6503	SO:0001583	missense			ENSG00000160862	HGNC:910	NM_001185	Approved	uc003ush.3	NA	D6W5T8|O60386|Q5XKQ4|Q8N4N0	ENST00000411734.1	37		.	.	.	.	.	.	.	.	.	.	C	10.36	1.328062	0.24080	.	.	ENSG00000160862	ENST00000292401;ENST00000411734	D;D	0.89050	-2.46;-2.46	1.51	-2.22	0.06952	MHC class I, alpha chain, alpha1/alpha2 (1);MHC classes I/II-like antigen recognition protein (1);	2.353210	0.02490	U	0.089339	T	0.72162	0.3426	N	0.02011	-0.69	0.22468	N	0.999077	B	0.06786	0.001	B	0.01281	0.0	T	0.63492	-0.6625	10	0.87932	D	0	.	3.7112	0.08420	0.0:0.2498:0.305:0.4452	.	27	P25311	ZA2G_HUMAN	H	27;24	ENSP00000292401:R27H;ENSP00000396093:R24H	ENSP00000292401:R27H	R	-	2	0	AZGP1	99407562	0.008000	0.16893	0.130000	0.21974	0.365000	0.29674	-0.562000	0.05950	-0.713000	0.04981	-0.643000	0.03959	CGT	AZGP1-003	PUTATIVE	basic	protein_coding	NA	protein_coding	OTTHUMT00000345055.1	68.544095	KEEP		-	81.717634	0.198718	31	125	---	---	---	---	1	1	97	263	0	125	33	134	0	125	2	0	0	0	0	0	0	33	134	0	125	2	TP
ALDH1A1	216	broad.mit.edu	37	9	75567900	75567900	+	Missense_Mutation	SNP	G	G	A	rs144704960		GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr9:75567900G>A	ENST00000297785.3	-	1	71	c.17C>T	c.(16-18)aCg>aTg	p.T6M	ALDH1A1_ENST00000482210.1_5'Flank|ALDH1A1_ENST00000376939.1_Missense_Mutation_p.T6M	NM_000689.4	NP_000680.2	P00352	AL1A1_HUMAN	aldehyde dehydrogenase 1 family, member A1	6		NA			cellular aldehyde metabolic process|ethanol oxidation|xenobiotic metabolic process	cytosol	aldehyde dehydrogenase (NAD) activity|androgen binding|Ras GTPase activator activity|retinal dehydrogenase activity			breast(1)|endometrium(1)|kidney(2)|large_intestine(4)|lung(5)|ovary(3)|prostate(1)	17					NADH(DB00157)|Tretinoin(DB00755)|Vitamin A(DB00162)	TAAGTCTGGCGTGCCTGAGGA	0.418	NA	NA					NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA	G	MET/THR	4,4402	8.1+/-20.4	0,4,2199	117	106	110	NA	17	-9.5	0	9	dbSNP_134	110	0,8598		0,0,4299	yes	missense	ALDH1A1	NM_000689.4	81	0,4,6498	AA,AG,GG	NA	0.0,0.0908,0.0308	benign	6/502	75567900	4,13000	2203	4299	6502	SO:0001583	missense			ENSG00000165092	HGNC:402		Approved	uc004ajd.3	NA	O00768|Q5SYR1	ENST00000297785.3	37	CCDS6644.1	.	.	.	.	.	.	.	.	.	.	G	4.881	0.163741	0.09287	9.08E-4	0.0	ENSG00000165092	ENST00000297785;ENST00000376939;ENST00000428593;ENST00000419959;ENST00000446946	T;T;T;T	0.76186	-1.0;-0.36;-0.28;-0.01	5.85	-9.48	0.00591	Aldehyde/histidinol dehydrogenase (1);	2.404540	0.01028	N	0.004092	T	0.42720	0.1215	N	0.03608	-0.345	0.09310	N	1	B	0.06786	0.001	B	0.04013	0.001	T	0.28235	-1.0050	10	0.25751	T	0.34	.	3.0939	0.06303	0.3042:0.0778:0.1222:0.4958	.	6	P00352	AL1A1_HUMAN	M	6;6;20;6;6	ENSP00000297785:T6M;ENSP00000366138:T6M;ENSP00000388026:T6M;ENSP00000401361:T6M	ENSP00000297785:T6M	T	-	2	0	ALDH1A1	74757720	0.000000	0.05858	0.000000	0.03702	0.048000	0.14542	-0.985000	0.03751	-0.924000	0.03780	-1.252000	0.01501	ACG	ALDH1A1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000052679.1	59.256414	KEEP		-	65.241931	0.242424	24	75	---	---	---	---	1	0.9360083	8	9	0	117	28	87	0	117	2	0	0	0	0	0	0	28	87	0	117	2	TP
OLFML2A	169611	broad.mit.edu	37	9	127566377	127566377	+	Silent	SNP	C	C	T			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr9:127566377C>T	ENST00000373580.3	+	6	924	c.924C>T	c.(922-924)aaC>aaT	p.N308N	OLFML2A_ENST00000288815.5_Silent_p.N94N	NM_182487.2	NP_872293.2	Q68BL7	OLM2A_HUMAN	olfactomedin-like 2A	308		NA								endometrium(5)|kidney(1)|large_intestine(8)|lung(8)|ovary(2)|upper_aerodigestive_tract(1)	25						CTGCAGACAACACCCTCCAGG	0.637	NA	NA					NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA						40	40	40	NA		NA	NA	9		NA											NA				127566377		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000185585	HGNC:27270	NM_182487	Approved	uc004bov.3	NA	Q5JTM5|Q5JTM6|Q6UXW1|Q7Z5V3	ENST00000373580.3	37	CCDS6857.2	.	.	.	.	.	.	.	.	.	.	C	0.531	-0.857784	0.02630	.	.	ENSG00000185585	ENST00000342100	.	.	.	4.97	-4.5	0.03493	.	.	.	.	.	T	0.48466	0.1501	.	.	.	0.19775	N	0.999952	.	.	.	.	.	.	T	0.55768	-0.8089	5	0.87932	D	0	.	11.979	0.53109	0.0:0.3197:0.0:0.6803	.	.	.	.	I	2	.	ENSP00000339766:T2I	T	+	2	0	OLFML2A	126606198	0.000000	0.05858	0.053000	0.19242	0.160000	0.22226	-2.260000	0.01177	-1.380000	0.02115	-1.202000	0.01658	ACA	OLFML2A-002	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000054046.2	43.056428	KEEP		+	46.736046	0.253731	17	50	---	---	---	---	1	0.8470812	2	9	0	50	22	57	0	50	2	0	0	0	0	0	0	22	57	0	50	2	TP
PRMT3	10196	broad.mit.edu	37	11	20448405	20448405	+	Silent	SNP	G	G	A			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr11:20448405G>A	ENST00000331079.6	+	10	1204	c.987G>A	c.(985-987)gaG>gaA	p.E329E	PRMT3_ENST00000437750.2_Silent_p.E267E	NM_001145167.1|NM_005788.3	NP_001138639.1|NP_005779.1	O60678	ANM3_HUMAN	protein arginine methyltransferase 3	329		NA					zinc ion binding			endometrium(2)|kidney(2)|large_intestine(4)|lung(8)|prostate(1)	17						TCATATCTGAGTGGATGGTGA	0.254	NA	NA					NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA						55	60	58	NA		NA	NA	11		NA											NA				20448405		2184	4281	6465	SO:0001819	synonymous_variant			ENSG00000185238	HGNC:30163	NM_005788	Approved	uc001mqb.3	NA	B4DUC7	ENST00000331079.6	37	CCDS7853.1																																																																																			PRMT3-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000387489.1	6.1332	KEEP		+	8.013894	0.166667	3	15	---	---	---	---	1	0.9799446	10	24	0	58	4	15	0	58	2	0	0	0	0	0	0	4	15	0	58	2	TP
ETV6	2120	broad.mit.edu	37	12	12044015	12044015	+	3'UTR	SNP	C	C	T			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr12:12044015C>T	ENST00000396373.4	+	0	1668					NM_001987.4	NP_001978.1	P41212	ETV6_HUMAN	ets variant 6	NA		NA				cytoplasm|nucleolus	protein domain specific binding|sequence-specific DNA binding|sequence-specific DNA binding transcription factor activity		ETV6/JAK2(11)|ETV6/ITPR2(2)|ETV6/NTRK3(238)	breast(3)|endometrium(1)|haematopoietic_and_lymphoid_tissue(15)|kidney(1)|large_intestine(6)|lung(10)|ovary(2)|pancreas(1)|skin(3)|upper_aerodigestive_tract(2)|urinary_tract(1)	45		all_cancers(2;1.88e-12)|Acute lymphoblastic leukemia(2;6.91e-39)|all_hematologic(2;2.7e-36)				GGCCAGCAGCCCAGGGAACCC	0.572	NA	NA	T	"""NTRK3, RUNX1, PDGFRB, ABL1, MN1, ABL2, FACL6, CHIC2, ARNT, JAK2, EVI1, CDX2, STL, HLXB9, MDS2, PER1, SYK, TTL, FGFR3, PAX5"""	"""congenital fibrosarcoma, multiple leukemia and lymphoma,  secretory breast, MDS, ALL"""		NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA				Dom	yes		12	12p13	2120	ets variant gene 6 (TEL oncogene)	NA	"""L, E, M"""	0							NA						48	50	49	NA		NA	NA	12		NA											NA				12044015		2203	4300	6503	SO:0001624	3_prime_UTR_variant			ENSG00000139083	HGNC:3495	NM_001987	Approved	uc001qzz.3	NA	A3QVP6|A8K076|Q9UMF6|Q9UMF7|Q9UMG0	ENST00000396373.4	37	CCDS8643.1																																																																																			ETV6-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000400130.2	142.5682	KEEP		+	150.558958	0.281915	53	135	---	---	---	---	1	1	27	50	0	66	56	137	0	66	2	0	0	0	0	0	0	56	137	0	66	2	TP
ACVRL1	94	broad.mit.edu	37	12	52309923	52309923	+	Silent	SNP	G	G	A			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr12:52309923G>A	ENST00000550683.1	+	7	1295	c.1194G>A	c.(1192-1194)caG>caA	p.Q398Q	ACVRL1_ENST00000388922.4_Silent_p.Q384Q|ACVRL1_ENST00000419526.2_Silent_p.Q210Q	NM_001077401.1	NP_001070869.1	P37023	ACVL1_HUMAN	activin A receptor type II-like 1	384	Protein kinase.	NA	I -> N (in HHT2; dbSNP:rs28936400).		blood vessel endothelial cell proliferation involved in sprouting angiogenesis|blood vessel maturation|negative regulation of cell growth|negative regulation of cell proliferation|negative regulation of endothelial cell migration|negative regulation of focal adhesion assembly|positive regulation of BMP signaling pathway|positive regulation of transcription, DNA-dependent|regulation of blood pressure|regulation of blood vessel endothelial cell migration|regulation of DNA replication|regulation of endothelial cell proliferation|transforming growth factor beta receptor signaling pathway|wound healing, spreading of epidermal cells	cell surface|integral to plasma membrane	activin binding|activin receptor activity, type I|ATP binding|metal ion binding|receptor signaling protein serine/threonine kinase activity|SMAD binding|transforming growth factor beta binding|transforming growth factor beta receptor activity			breast(1)|endometrium(2)|kidney(1)|large_intestine(4)|lung(9)|prostate(1)|skin(1)|urinary_tract(1)	20				BRCA - Breast invasive adenocarcinoma(357;0.0991)	Adenosine triphosphate(DB00171)	TGGACGAGCAGATCCGCACGG	0.602	NA	NA					NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA						105	89	95	NA		NA	NA	12		NA											NA				52309923		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000139567	HGNC:175		Approved	uc001rzk.3	NA	A6NGA8	ENST00000550683.1	37																																																																																				ACVRL1-002	KNOWN	basic	protein_coding	NA	protein_coding	OTTHUMT00000404523.2	116.096326	KEEP		+	123.620719	0.27439	45	119	---	---	---	---	1	0.993808	7	18	0	118	46	126	0	118	2	0	0	0	0	0	0	46	126	0	118	2	TP
ESPL1	9700	broad.mit.edu	37	12	53687195	53687195	+	Silent	SNP	C	C	T			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr12:53687195C>T	ENST00000257934.4	+	31	6391	c.6300C>T	c.(6298-6300)ccC>ccT	p.P2100P	PFDN5_ENST00000351500.3_5'Flank|PFDN5_ENST00000551018.1_5'Flank|PFDN5_ENST00000334478.4_5'Flank|ESPL1_ENST00000552462.1_Silent_p.P2100P|PFDN5_ENST00000550846.1_5'Flank	NM_012291.4	NP_036423.4	Q14674	ESPL1_HUMAN	extra spindle pole bodies homolog 1 (S. cerevisiae)	2100		NA			apoptosis|cytokinesis|establishment of mitotic spindle localization|mitotic sister chromatid segregation|negative regulation of sister chromatid cohesion|positive regulation of mitotic metaphase/anaphase transition|proteolysis	centrosome|nucleus	cysteine-type peptidase activity|protein binding			breast(1)|central_nervous_system(1)|endometrium(7)|kidney(10)|large_intestine(12)|lung(21)|ovary(2)|prostate(3)|skin(4)|upper_aerodigestive_tract(1)|urinary_tract(8)	70						GCCAAGCTCCCCGACTCAAGT	0.567	NA	NA					NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Colon(53;1069 1201 2587 5382)							NA		NA		0							NA						65	66	65	NA		NA	NA	12		NA											NA				53687195		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000135476	HGNC:16856	NM_012291	Approved	uc001sck.2	NA		ENST00000257934.4	37	CCDS8852.1																																																																																			ESPL1-201	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000406899.2	30.77069	KEEP		+	38.94324	0.178571	15	69	---	---	---	---	1	0.4806602	2	6	0	104	20	85	0	104	2	0	0	0	0	0	0	20	85	0	104	2	TP
CIT	11113	broad.mit.edu	37	12	120138625	120138625	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr12:120138625C>T	ENST00000392521.2	-	44	5603	c.5548G>A	c.(5548-5550)Gga>Aga	p.G1850R	CIT_ENST00000537607.1_5'UTR|CIT_ENST00000261833.7_Missense_Mutation_p.G1808R|RP1-127H14.3_ENST00000535109.1_3'UTR	NM_001206999.1	NP_001193928.1	O14578	CTRO_HUMAN	citron (rho-interacting, serine/threonine kinase 21)	1808	CNH.	NA			intracellular signal transduction		ATP binding|metal ion binding|protein serine/threonine kinase activity|SH3 domain binding|small GTPase regulator activity			breast(6)|endometrium(9)|kidney(4)|large_intestine(15)|liver(1)|lung(29)|ovary(7)|prostate(4)|skin(3)|stomach(1)|upper_aerodigestive_tract(1)|urinary_tract(6)	86	all_neural(191;0.0804)|Medulloblastoma(191;0.0922)	Myeloproliferative disorder(1001;0.0255)		BRCA - Breast invasive adenocarcinoma(302;0.211)		ACGAACACTCCAAATTCTGCA	0.547	NA	NA					NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA						140	112	122	NA		NA	NA	12		NA											NA				120138625		2203	4300	6503	SO:0001583	missense			ENSG00000122966	HGNC:1985	NM_007174	Approved	uc001txj.2	NA	Q6XUH8|Q86UQ9|Q9UPZ7	ENST00000392521.2	37	CCDS55891.1	.	.	.	.	.	.	.	.	.	.	C	35	5.518339	0.96416	.	.	ENSG00000122966	ENST00000392521;ENST00000261833	T;T	0.05717	3.4;3.4	5.6	5.6	0.85130	Citron-like (3);	0.000000	0.85682	D	0.000000	T	0.30008	0.0751	M	0.81112	2.525	0.80722	D	1	D;D;D	0.89917	1.0;1.0;1.0	D;D;D	0.97110	1.0;1.0;1.0	T	0.01591	-1.1317	10	0.87932	D	0	.	19.6154	0.95632	0.0:1.0:0.0:0.0	.	1850;1808;1326	Q2M5E1;O14578;O14578-3	.;CTRO_HUMAN;.	R	1850;1808	ENSP00000376306:G1850R;ENSP00000261833:G1808R	ENSP00000261833:G1808R	G	-	1	0	CIT	118623008	1.000000	0.71417	0.999000	0.59377	0.957000	0.61999	7.790000	0.85794	2.652000	0.90054	0.650000	0.86243	GGA	CIT-005	NOVEL	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000401847.1	50.433887	KEEP		-	54.519686	0.2625	21	59	---	---	---	---	1	0.7785822	4	6	0	75	27	76	0	75	2	0	0	0	0	0	0	27	76	0	75	2	TP
PAN3	255967	broad.mit.edu	37	13	28794510	28794510	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr13:28794510C>T	ENST00000399613.1	+	5	458	c.395C>T	c.(394-396)gCg>gTg	p.A132V	PAN3_ENST00000380958.3_Missense_Mutation_p.A332V			Q58A45	PAN3_HUMAN	PAN3 poly(A) specific ribonuclease subunit homolog (S. cerevisiae)	332	Interaction with polyadenylate-binding protein.	NA			nuclear-transcribed mRNA catabolic process, nonsense-mediated decay|nuclear-transcribed mRNA poly(A) tail shortening	centrosome|cytosol	ATP binding|protein kinase activity			endometrium(1)|kidney(3)|large_intestine(7)|lung(9)|ovary(1)|prostate(1)|skin(1)|upper_aerodigestive_tract(1)	24	Acute lymphoblastic leukemia(6;0.04)	Lung SC(185;0.0262)	Colorectal(13;0.000334)	all cancers(112;0.0102)|Epithelial(112;0.0803)|GBM - Glioblastoma multiforme(144;0.121)|OV - Ovarian serous cystadenocarcinoma(117;0.13)|Lung(94;0.174)		GCTGGATTAGCGCCAGGTAAG	0.423	NA	NA					NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA						162	163	163	NA		NA	NA	13		NA											NA				28794510		2203	4300	6503	SO:0001583	missense			ENSG00000152520	HGNC:29991	NM_175854	Approved	uc001urz.3	NA	A0N0X1|A1A4Y8|A1A4Y9|B1ALF1|B7Z3W7|Q0D2P2|Q5HYG6|Q5T515|Q5T516|Q5TBA0|Q76E13|Q8NBA6	ENST00000399613.1	37		.	.	.	.	.	.	.	.	.	.	C	18.99	3.740449	0.69304	.	.	ENSG00000152520	ENST00000380958;ENST00000399613	T;T	0.47869	0.83;0.87	5.6	5.6	0.85130	.	0.050294	0.85682	D	0.000000	T	0.35098	0.0920	N	0.19112	0.55	0.80722	D	1	P;P;B	0.51791	0.948;0.669;0.44	B;B;B	0.39503	0.301;0.036;0.016	T	0.11567	-1.0582	10	0.29301	T	0.29	-13.567	19.6153	0.95632	0.0:1.0:0.0:0.0	.	332;332;278	Q58A45-4;Q58A45;Q58A45-3	.;PAN3_HUMAN;.	V	332;132	ENSP00000370345:A332V;ENSP00000382522:A132V	ENSP00000370345:A332V	A	+	2	0	PAN3	27692510	1.000000	0.71417	0.999000	0.59377	0.981000	0.71138	5.642000	0.67888	2.630000	0.89119	0.555000	0.69702	GCG	PAN3-001	KNOWN	basic	protein_coding	NA	protein_coding	OTTHUMT00000044317.3	282.412086	KEEP		+	297.581329	0.283333	102	258	---	---	---	---	1	0.8942173	8	4	1	303	113	284	1	303	2	0	0	0	0	0	0	113	284	1	303	2	TP
TRIP11	9321	broad.mit.edu	37	14	92470681	92470681	+	Silent	SNP	C	C	T			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr14:92470681C>T	ENST00000267622.4	-	11	4012	c.3639G>A	c.(3637-3639)aaG>aaA	p.K1213K		NM_004239.3	NP_004230.2	Q15643	TRIPB_HUMAN	thyroid hormone receptor interactor 11	1213		NA			transcription from RNA polymerase II promoter	cytoskeleton|Golgi apparatus|membrane|nucleus	protein binding|transcription coactivator activity	p.K1213N(1)		breast(3)|central_nervous_system(2)|endometrium(1)|kidney(8)|large_intestine(12)|lung(17)|ovary(7)|pancreas(1)|prostate(1)|skin(3)|upper_aerodigestive_tract(2)|urinary_tract(1)	58				COAD - Colon adenocarcinoma(157;0.223)		GCTGTTTTAACTTGTCACGTT	0.428	NA	NA	T	PDGFRB	AML		NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Ovarian(84;609 1888 9852 42686)		Dom	yes		14	14q31-q32	9321	thyroid hormone receptor interactor 11	NA	L	1	Substitution - Missense(1)	breast(1)					NA						86	81	83	NA		NA	NA	14		NA											NA				92470681		2203	4300	6503	SO:0001819	synonymous_variant				HGNC:12305		Approved	uc001xzy.3	NA	O14689|O15154|O95949	ENST00000267622.4	37	CCDS9899.1	.	.	.	.	.	.	.	.	.	.	C	0.011	-1.694849	0.00731	.	.	ENSG00000100815	ENST00000554357	.	.	.	5.46	-4.73	0.03259	.	.	.	.	.	T	0.57431	0.2053	.	.	.	0.39028	D	0.95987	.	.	.	.	.	.	T	0.59852	-0.7376	4	.	.	.	.	13.457	0.61204	0.0:0.5463:0.0:0.4537	.	.	.	.	I	929	.	.	V	-	1	0	TRIP11	91540434	0.022000	0.18835	0.000000	0.03702	0.201000	0.24016	-0.645000	0.05409	-0.919000	0.03803	-0.391000	0.06502	GTT	TRIP11-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000411823.1	86.481166	KEEP		-	94.740882	0.244604	34	105	---	---	---	---	1	0.9443499	6	12	0	107	35	112	0	107	2	0	0	0	0	0	0	35	112	0	107	2	TP
PRIMA1	145270	broad.mit.edu	37	14	94203651	94203651	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr14:94203651C>T	ENST00000393140.1	-	4	397	c.295G>A	c.(295-297)Gta>Ata	p.V99I	PRIMA1_ENST00000393143.1_Missense_Mutation_p.V99I|PRIMA1_ENST00000316227.3_Missense_Mutation_p.V99I	NM_178013.3	NP_821092.1	Q86XR5	PRIMA_HUMAN	proline rich membrane anchor 1	99		NA			neurotransmitter catabolic process	cell junction|integral to membrane|synapse				endometrium(1)|large_intestine(2)|lung(3)|skin(1)	7		all_cancers(154;0.127)		Epithelial(152;0.138)|COAD - Colon adenocarcinoma(157;0.229)		GCACAGCATACGGCAATGATG	0.532	NA	NA					NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA						132	122	125	NA		NA	NA	14		NA											NA				94203651		2203	4300	6503	SO:0001583	missense			ENSG00000175785	HGNC:18319	NM_178013	Approved	uc001ybw.1	NA	Q86XR6	ENST00000393140.1	37	CCDS9912.1	.	.	.	.	.	.	.	.	.	.	C	18.82	3.705227	0.68615	.	.	ENSG00000175785	ENST00000393140;ENST00000393143;ENST00000316227	.	.	.	4.95	4.06	0.47325	.	0.194334	0.30584	N	0.009306	T	0.47414	0.1444	N	0.12746	0.255	0.38731	D	0.953673	D	0.67145	0.996	P	0.56563	0.801	T	0.55630	-0.8111	9	0.52906	T	0.07	-7.581	12.1732	0.54169	0.0:0.9193:0.0:0.0807	.	99	Q86XR5	PRIMA_HUMAN	I	99	.	ENSP00000320948:V99I	V	-	1	0	PRIMA1	93273404	0.658000	0.27402	0.127000	0.21898	0.987000	0.75469	2.193000	0.42658	1.219000	0.43474	-0.263000	0.10527	GTA	PRIMA1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000280658.1	43.180118	KEEP		-	49.538156	0.218391	19	68	---	---	---	---	1	0.7845931	4	8	0	88	22	76	0	88	2	0	0	0	0	0	0	22	76	0	88	2	TP
AKT1	207	broad.mit.edu	37	14	105241276	105241276	+	Splice_Site	SNP	G	G	A			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr14:105241276G>A	ENST00000554581.1	-	6	2112	c.633_splice	c.e6+1	p.T211_splice	AKT1_ENST00000402615.2_Splice_Site_p.T211_splice|AKT1_ENST00000554848.1_Splice_Site_p.T211_splice|AKT1_ENST00000349310.3_Splice_Site_p.T211_splice|AKT1_ENST00000407796.2_Splice_Site_p.T211_splice|AKT1_ENST00000554585.1_5'Flank|AKT1_ENST00000555458.1_5'Flank|AKT1_ENST00000554192.1_5'Flank|AKT1_ENST00000544168.1_Splice_Site_p.T149_splice|AKT1_ENST00000555528.1_Splice_Site_p.T211_splice			P31749	AKT1_HUMAN	v-akt murine thymoma viral oncogene homolog 1	211	Protein kinase.	NA			activation of pro-apoptotic gene products|activation-induced cell death of T cells|endocrine pancreas development|G-protein coupled receptor protein signaling pathway|glucose metabolic process|glycogen biosynthetic process|induction of apoptosis by intracellular signals|insulin receptor signaling pathway|insulin-like growth factor receptor signaling pathway|mRNA metabolic process|negative regulation of fatty acid beta-oxidation|negative regulation of plasma membrane long-chain fatty acid transport|negative regulation of protein kinase activity|nerve growth factor receptor signaling pathway|nitric oxide biosynthetic process|peptidyl-serine phosphorylation|phosphatidylinositol-mediated signaling|platelet activation|positive regulation of blood vessel endothelial cell migration|positive regulation of cell growth|positive regulation of cyclin-dependent protein kinase activity involved in G1/S|positive regulation of establishment of protein localization in plasma membrane|positive regulation of fat cell differentiation|positive regulation of glucose import|positive regulation of glycogen biosynthetic process|positive regulation of lipid biosynthetic process|positive regulation of nitric oxide biosynthetic process|positive regulation of nitric-oxide synthase activity|positive regulation of peptidyl-serine phosphorylation|positive regulation of sequence-specific DNA binding transcription factor activity|protein autophosphorylation|protein import into nucleus, translocation|regulation of neuron projection development|regulation of translation|response to fluid shear stress|response to heat|response to UV-A|T cell costimulation	cytosol|nucleoplasm|plasma membrane	enzyme binding|identical protein binding|nitric-oxide synthase regulator activity|phosphatidylinositol-3,4,5-trisphosphate binding|phosphatidylinositol-3,4-bisphosphate binding|protein serine/threonine kinase activity			NS(3)|breast(97)|central_nervous_system(2)|endometrium(13)|haematopoietic_and_lymphoid_tissue(4)|kidney(1)|large_intestine(7)|lung(10)|ovary(2)|pancreas(1)|prostate(6)|skin(5)|thyroid(10)|urinary_tract(15)	176		all_cancers(154;3.77e-06)|all_lung(585;3.24e-07)|all_epithelial(191;3.45e-05)|all_neural(303;0.0459)|Melanoma(154;0.155)	all cancers(16;0.000486)|OV - Ovarian serous cystadenocarcinoma(23;0.00647)|Epithelial(46;0.0153)|GBM - Glioblastoma multiforme(11;0.116)	all cancers(159;0.0107)|OV - Ovarian serous cystadenocarcinoma(161;0.0132)|Epithelial(152;0.243)	Adenosine triphosphate(DB00171)|Arsenic trioxide(DB01169)	CCCACTCACTGTGAGGAAGGG	0.647	NA	1	Mis		"""breast, colorectal, ovarian, NSCLC"""		NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA				Dom	yes		14	14q32.32	207	v-akt murine thymoma viral oncogene homolog 1	NA	E	0							NA						74	69	70	NA		NA	NA	14		NA											NA				105241276		2203	4300	6503	SO:0001630	splice_region_variant				HGNC:391	NM_005163	Approved	uc001ypn.3	NA	B2RAM5|Q9BWB6	ENST00000554581.1	37	CCDS9994.1	.	.	.	.	.	.	.	.	.	.	G	23.5	4.422472	0.83559	.	.	ENSG00000142208	ENST00000554581;ENST00000407796;ENST00000349310;ENST00000402615;ENST00000555528;ENST00000544168;ENST00000554848	T;T;T;T;T;T;T	0.20598	2.06;2.06;2.06;2.06;2.06;2.06;2.06	3.92	3.92	0.45320	Serine/threonine-protein kinase-like domain (1);Serine/threonine-protein kinase, catalytic  domain (1);Protein kinase-like domain (1);Protein kinase, catalytic domain (1);	0.000000	0.85682	D	0.000000	T	0.19927	0.0479	N	0.01729	-0.75	0.80722	D	1	D	0.69078	0.997	D	0.72625	0.978	T	0.47749	-0.9093	10	0.28530	T	0.3	.	16.0891	0.81080	0.0:0.0:1.0:0.0	.	211	P31749	AKT1_HUMAN	I	211;211;211;211;211;149;211	ENSP00000451828:T211I;ENSP00000384293:T211I;ENSP00000270202:T211I;ENSP00000385326:T211I;ENSP00000450688:T211I;ENSP00000443897:T149I;ENSP00000451166:T211I	ENSP00000270202:T211I	T	-	2	0	AKT1	104312321	1.000000	0.71417	0.946000	0.38457	0.892000	0.51952	7.544000	0.82117	2.011000	0.59026	0.491000	0.48974	ACA	AKT1-005	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000410418.1	76.539565	KEEP	Missense_Mutation	-	82.78085	0.262295	32	90	---	---	---	---	1	1	171	344	0	98	37	101	0	98	2	0	0	0	0	0	0	37	101	0	98	2	TP
MPI	4351	broad.mit.edu	37	15	75189293	75189293	+	3'UTR	SNP	C	C	T			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr15:75189293C>T	ENST00000564003.1	+	0	1192				MPI_ENST00000535694.1_Intron|MPI_ENST00000323744.6_Intron|MPI_ENST00000566377.1_Intron|MPI_ENST00000563786.1_Intron|MPI_ENST00000352410.4_Intron			P34949	MPI_HUMAN	mannose phosphate isomerase	NA		NA			dolichol-linked oligosaccharide biosynthetic process|GDP-mannose biosynthetic process|post-translational protein modification|protein N-linked glycosylation via asparagine	cytosol	mannose-6-phosphate isomerase activity|zinc ion binding			endometrium(2)|kidney(1)|large_intestine(1)|lung(2)|ovary(2)|upper_aerodigestive_tract(1)	9						TTAGGAGGCCCAGAACTGGAG	0.468	NA	NA					NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA						NA	NA	NA	NA		NA	NA			NA											NA				NA		NA	NA	NA	SO:0001624	3_prime_UTR_variant			ENSG00000178802	HGNC:7216		Approved	uc002azc.1	NA	A8K8K9|Q96AB0	ENST00000564003.1	37																																																																																				MPI-004	PUTATIVE	basic	protein_coding	NA	protein_coding	OTTHUMT00000420286.2	57.692917	KEEP		+	65.30165	0.215686	22	80	---	---	---	---	1	1	4	7	0	64	23	81	0	64	2	0	0	0	0	0	0	23	81	0	64	2	TP
NF1	4763	broad.mit.edu	37	17	29556481	29556481	+	Nonsense_Mutation	SNP	C	C	T			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Invalid,Invalid,Valid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr17:29556481C>T	ENST00000358273.4	+	21	3231	c.2848C>T	c.(2848-2850)Cag>Tag	p.Q950*	NF1_ENST00000356175.3_Nonsense_Mutation_p.Q950*	NM_001042492.2	NP_001035957.1	P21359	NF1_HUMAN	neurofibromin 1	950		NA			actin cytoskeleton organization|adrenal gland development|artery morphogenesis|camera-type eye morphogenesis|cerebral cortex development|collagen fibril organization|forebrain astrocyte development|forebrain morphogenesis|heart development|liver development|MAPKKK cascade|metanephros development|myelination in peripheral nervous system|negative regulation of cell migration|negative regulation of endothelial cell proliferation|negative regulation of MAP kinase activity|negative regulation of MAPKKK cascade|negative regulation of neuroblast proliferation|negative regulation of oligodendrocyte differentiation|negative regulation of transcription factor import into nucleus|osteoblast differentiation|phosphatidylinositol 3-kinase cascade|pigmentation|positive regulation of adenylate cyclase activity|positive regulation of neuron apoptosis|Ras protein signal transduction|regulation of blood vessel endothelial cell migration|regulation of bone resorption|response to hypoxia|smooth muscle tissue development|spinal cord development|sympathetic nervous system development|visual learning|wound healing	axon|cytoplasm|dendrite|intrinsic to internal side of plasma membrane|nucleus	protein binding|Ras GTPase activator activity	p.0?(8)|p.?(4)	NF1/ACCN1(2)	autonomic_ganglia(12)|breast(11)|central_nervous_system(72)|cervix(6)|endometrium(12)|haematopoietic_and_lymphoid_tissue(59)|kidney(9)|large_intestine(39)|liver(1)|lung(80)|ovary(20)|pancreas(2)|prostate(2)|skin(8)|soft_tissue(249)|stomach(2)|thyroid(1)|upper_aerodigestive_tract(5)|urinary_tract(9)	599		all_cancers(10;1.29e-12)|all_epithelial(10;0.00347)|all_hematologic(16;0.00556)|Acute lymphoblastic leukemia(14;0.00593)|Breast(31;0.014)|Myeloproliferative disorder(56;0.0255)|all_lung(9;0.0321)|Lung NSC(157;0.0659)		UCEC - Uterine corpus endometrioid carcinoma (4;4.38e-05)|all cancers(4;1.64e-26)|Epithelial(4;9.15e-23)|OV - Ovarian serous cystadenocarcinoma(4;3.58e-21)|GBM - Glioblastoma multiforme(4;0.00146)		CTCCCAAGGACAGGTAAAGTG	0.348	NA	NA	"""D, Mis, N, F, S, O"""		"""neurofibroma, glioma"""	"""neurofibroma, glioma"""	NA	NA	Neurofibromatosis, type 1	TCGA GBM(6;<1E-08)|TSP Lung(7;0.0071)|TCGA Ovarian(3;0.0088)				NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA			yes	Rec	yes	Neurofibromatosis type 1	17	17q12	4763	neurofibromatosis type 1 gene	NA	O	12	Whole gene deletion(8)|Unknown(4)	soft_tissue(7)|autonomic_ganglia(2)|central_nervous_system(2)|lung(1)					NA						78	80	79	NA		NA	NA	17		NA											NA				29556481		2200	4297	6497	SO:0001587	stop_gained	Familial Cancer Database	NF1, von Recklinghausen disease, incl.: Hereditary Spinal Neurofibromatosis, Neurofibromatosis-Noonan syndrome	ENSG00000196712	HGNC:7765	NM_000267	Approved	uc002hgg.3	NA	O00662|Q14284|Q14930|Q9UMK3	ENST00000358273.4	37	CCDS42292.1	.	.	.	.	.	.	.	.	.	.	.	44	11.090366	0.99514	.	.	ENSG00000196712	ENST00000358273;ENST00000356175;ENST00000456735	.	.	.	5.48	5.48	0.80851	.	0.057246	0.64402	D	0.000001	.	.	.	.	.	.	0.80722	D	1	.	.	.	.	.	.	.	.	.	.	0.42905	T	0.14	.	19.3532	0.94398	0.0:1.0:0.0:0.0	.	.	.	.	X	950;950;616	.	ENSP00000348498:Q950X	Q	+	1	0	NF1	26580607	1.000000	0.71417	1.000000	0.80357	0.961000	0.63080	7.456000	0.80751	2.594000	0.87642	0.455000	0.32223	CAG	NF1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000256351.2	119.98167	KEEP		+	129.23387	0.264865	49	136	---	---	---	---	0	0.4874792	1	5	0	165	52	150	0	165	2	1	1	101	396	0	720	52	150	0	165	2	TP
NKIRAS2	28511	broad.mit.edu	37	17	40169441	40169441	+	5'UTR	SNP	G	G	T			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr17:40169441G>T	ENST00000307641.5	+	0	404				NKIRAS2_ENST00000393884.2_5'Flank|NKIRAS2_ENST00000393880.1_5'Flank|NKIRAS2_ENST00000479407.1_5'Flank|NKIRAS2_ENST00000462043.2_5'Flank|DNAJC7_ENST00000457167.4_5'UTR|NKIRAS2_ENST00000449471.4_5'Flank|NKIRAS2_ENST00000393881.3_5'Flank|DNAJC7_ENST00000589547.1_5'Flank|NKIRAS2_ENST00000316082.4_5'Flank|DNAJC7_ENST00000316603.7_5'Flank|DNAJC7_ENST00000426588.3_5'Flank|NKIRAS2_ENST00000393885.4_5'Flank	NM_001001349.2	NP_001001349.1	Q9NYR9	KBRS2_HUMAN	NFKB inhibitor interacting Ras-like 2	NA		NA			I-kappaB kinase/NF-kappaB cascade|small GTPase mediated signal transduction	cytoplasm	GTP binding|GTPase activity			large_intestine(2)|lung(5)|ovary(1)|upper_aerodigestive_tract(1)	9		all_cancers(22;1.1e-05)|Breast(137;0.000143)|all_epithelial(22;0.000319)				CCATCTTACCGCCGGGACCAG	0.692	NA	NA					NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA						40	44	43	NA		NA	NA	17		NA											NA				40169441		1975	4142	6117	SO:0001623	5_prime_UTR_variant			ENSG00000168256	HGNC:17898	NM_017595	Approved	uc002hys.3	NA	A6NCZ5|B3KNN0|Q6PK52|Q96KC7|Q9NSX1	ENST00000307641.5	37	CCDS11415.1																																																																																			NKIRAS2-010	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000257457.1	71.051573	KEEP		+	72.53581	0.347222	25	47	---	---	---	---	1	0.9979463	9	19	0	72	40	102	0	72	2	0	0	0	0	0	0	40	102	0	72	2	TP
ZNF532	55205	broad.mit.edu	37	18	56587754	56587754	+	Silent	SNP	C	C	T			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr18:56587754C>T	ENST00000336078.4	+	4	3011	c.2235C>T	c.(2233-2235)gaC>gaT	p.D745D	ZNF532_ENST00000591808.1_Silent_p.D745D|ZNF532_ENST00000589288.1_Silent_p.D745D|ZNF532_ENST00000591230.1_Silent_p.D745D|ZNF532_ENST00000591083.1_Silent_p.D745D	NM_018181.4	NP_060651.2	Q9HCE3	ZN532_HUMAN	zinc finger protein 532	745		NA			regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	DNA binding|zinc ion binding			breast(5)|central_nervous_system(1)|cervix(2)|endometrium(14)|kidney(1)|large_intestine(9)|lung(14)|prostate(1)|skin(4)|urinary_tract(1)	52						TAGATGAAGACCCCTCCAAAC	0.483	NA	NA					NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA						45	41	42	NA		NA	NA	18		NA											NA				56587754		2203	4300	6503	SO:0001819	synonymous_variant			ENSG00000074657	HGNC:30940	NM_018181	Approved	uc002lho.3	NA	Q4G0V6|Q7L7Z7|Q96QR7|Q9NVJ6	ENST00000336078.4	37	CCDS11969.1																																																																																			ZNF532-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000256130.1	43.684157	KEEP		+	49.090452	0.231707	19	63	---	---	---	---	1	1	82	82	0	66	23	63	0	66	2	0	0	0	0	0	0	23	63	0	66	2	TP
ZNF516	9658	broad.mit.edu	37	18	74154336	74154336	+	Silent	SNP	G	G	A			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr18:74154336G>A	ENST00000443185.2	-	3	992	c.675C>T	c.(673-675)acC>acT	p.T225T	ZNF516_ENST00000524431.2_5'UTR	NM_014643.3	NP_055458.1	Q92618	ZN516_HUMAN	zinc finger protein 516	225		NA			regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	DNA binding|zinc ion binding			central_nervous_system(2)|endometrium(3)|kidney(2)|large_intestine(7)|lung(11)|ovary(1)|prostate(2)|skin(1)|upper_aerodigestive_tract(1)|urinary_tract(2)	32		Prostate(75;0.0869)|Esophageal squamous(42;0.129)		OV - Ovarian serous cystadenocarcinoma(15;7.64e-06)|BRCA - Breast invasive adenocarcinoma(31;0.238)		GCCCCTGCGCGGTGATGTGGT	0.697	NA	NA					NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA						18	20	20	NA		NA	NA	18		NA											NA				74154336		2146	4251	6397	SO:0001819	synonymous_variant				HGNC:28990	NM_014643	Approved	uc021ulp.1	NA		ENST00000443185.2	37																																																																																				ZNF516-201	KNOWN	basic|exp_conf	protein_coding	NA	protein_coding		28.440557	KEEP		-	32.69433	0.220339	13	46	---	---	---	---	1	0.7000241	3	6	0	42	18	54	0	42	2	0	0	0	0	0	0	18	54	0	42	2	TP
LDLR	3949	broad.mit.edu	37	19	11224366	11224366	+	Missense_Mutation	SNP	G	G	C			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr19:11224366G>C	ENST00000558518.1	+	10	1701	c.1514G>C	c.(1513-1515)gGc>gCc	p.G505A	LDLR_ENST00000557933.1_Missense_Mutation_p.G505A|LDLR_ENST00000535915.1_Missense_Mutation_p.G464A|LDLR_ENST00000455727.2_Missense_Mutation_p.G337A|LDLR_ENST00000545707.1_Missense_Mutation_p.G378A|LDLR_ENST00000558013.1_Missense_Mutation_p.G505A	NM_000527.4|NM_001195798.1	NP_000518.1|NP_001182727.1	P01130	LDLR_HUMAN	low density lipoprotein receptor	505		NA			cholesterol homeostasis|cholesterol metabolic process|interspecies interaction between organisms|intestinal cholesterol absorption|low-density lipoprotein particle clearance|receptor-mediated endocytosis	clathrin-coated endocytic vesicle membrane|coated pit|early endosome|endosome membrane|external side of plasma membrane|integral to plasma membrane|low-density lipoprotein particle|lysosome	calcium ion binding|low-density lipoprotein receptor activity|protein binding|very-low-density lipoprotein particle receptor activity	p.?(1)		breast(2)|endometrium(2)|large_intestine(5)|lung(8)|ovary(2)|pancreas(1)|prostate(1)|skin(3)|upper_aerodigestive_tract(1)|urinary_tract(1)	26		Lung NSC(9;0.000245)|Renal(1328;0.0007)|Hepatocellular(1079;0.0524)		GBM - Glioblastoma multiforme(1328;1.36e-05)|STAD - Stomach adenocarcinoma(1328;0.000766)|Lung(535;0.197)	Methyl aminolevulinate(DB00992)|Porfimer(DB00707)	GATACCAAGGGCGTGAAGAGG	0.592	NA	NA					NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		GBM(18;201 575 7820 21545)							NA		NA		1	Unknown(1)	lung(1)	GRCh37	CM023641	LDLR	M	NA						114	91	99	NA		NA	NA	19		NA											NA				11224366		2203	4300	6503	SO:0001583	missense			ENSG00000130164	HGNC:6547		Approved	uc002mqk.4	NA	C0JYY8|Q53ZD9|Q9UDH7	ENST00000558518.1	37	CCDS12254.1	.	.	.	.	.	.	.	.	.	.	G	16.88	3.244047	0.59103	.	.	ENSG00000130164	ENST00000252444;ENST00000545707;ENST00000535915;ENST00000455727	D;D;D	0.99232	-5.6;-5.6;-5.6	4.72	4.72	0.59763	Six-bladed beta-propeller, TolB-like (1);Growth factor, receptor (1);	0.000000	0.64402	D	0.000015	D	0.99533	0.9833	H	0.94964	3.605	0.80722	D	1	P;D;D;D;D;P	0.58268	0.939;0.982;0.967;0.982;0.967;0.942	P;D;P;P;P;P	0.65233	0.894;0.933;0.904;0.904;0.904;0.904	D	0.98057	1.0391	10	0.62326	D	0.03	.	16.4495	0.83974	0.0:0.0:1.0:0.0	.	337;378;384;464;517;505	B4DR00;B4DJZ8;B4DII3;B4DTQ3;Q59FQ1;P01130	.;.;.;.;.;LDLR_HUMAN	A	505;378;464;337	ENSP00000437639:G378A;ENSP00000440520:G464A;ENSP00000397829:G337A	ENSP00000252444:G505A	G	+	2	0	LDLR	11085366	1.000000	0.71417	0.092000	0.20876	0.008000	0.06430	9.220000	0.95180	2.186000	0.69663	0.555000	0.69702	GGC	LDLR-003	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000415973.2	66.908978	KEEP		+	83.888189	0.172619	29	139	---	---	---	---	1	0.9971014	14	35	0	101	32	161	0	101	2	0	0	0	0	0	0	32	161	0	101	2	TP
ZNF709	163051	broad.mit.edu	37	19	12575498	12575498	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr19:12575498G>A	ENST00000397732.3	-	4	1409	c.1238C>T	c.(1237-1239)aCt>aTt	p.T413I	ZNF709_ENST00000428311.1_Missense_Mutation_p.T413I|CTD-3105H18.18_ENST00000598753.1_Intron	NM_152601.3	NP_689814.1	Q8N972	ZN709_HUMAN	zinc finger protein 709	413		NA			regulation of transcription, DNA-dependent|transcription, DNA-dependent	nucleus	DNA binding|zinc ion binding	p.T413I(2)		large_intestine(3)|upper_aerodigestive_tract(3)	6						TCCAGTGTGAGTTCTTTCATG	0.418	NA	NA					NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		GBM(33;565 669 12371 29134 51667)							NA		NA		2	Substitution - Missense(2)	kidney(1)|skin(1)					NA						106	111	109	NA		NA	NA	19		NA											NA				12575498		2202	4299	6501	SO:0001583	missense			ENSG00000242852	HGNC:20629	NM_152601	Approved	uc002mtv.4	NA		ENST00000397732.3	37	CCDS42504.1	.	.	.	.	.	.	.	.	.	.	G	0.031	-1.333208	0.01298	.	.	ENSG00000242852;ENSG00000196826	ENST00000397732;ENST00000428311	T;T	0.06142	3.34;3.34	3.05	-3.79	0.04320	Zinc finger, C2H2-like (1);Zinc finger, C2H2 (3);Zinc finger, C2H2-type/integrase, DNA-binding (1);	0.000000	0.35067	N	0.003471	T	0.01976	0.0062	N	0.11000	0.08	0.09310	N	1	B	0.28258	0.205	B	0.25884	0.064	T	0.43814	-0.9368	10	0.02654	T	1	.	5.8441	0.18652	0.2644:0.3999:0.3357:0.0	.	413	Q8N972	ZN709_HUMAN	I	413	ENSP00000380840:T413I;ENSP00000404127:T413I	ENSP00000404127:T413I	T	-	2	0	ZNF709;CTD-2192J16.17	12436498	0.000000	0.05858	0.002000	0.10522	0.972000	0.66771	-2.485000	0.00979	-0.610000	0.05716	0.591000	0.81541	ACT	ZNF709-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000344088.1	-75.596473	KEEP		-	8.054867	0.015873	5	310	---	---	---	---	1	0.007317786	3	7	0	174	3	329	0	174	2	0	0	0	0	0	0	3	329	0	174	2	TP
GIPC1	10755	broad.mit.edu	37	19	14591540	14591540	+	Silent	SNP	C	C	G			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr19:14591540C>G	ENST00000393033.4	-	5	608	c.339G>C	c.(337-339)ctG>ctC	p.L113L	GIPC1_ENST00000586027.1_Silent_p.L113L|GIPC1_ENST00000591349.1_Silent_p.L16L|GIPC1_ENST00000393028.1_Silent_p.L16L|GIPC1_ENST00000393029.3_Silent_p.L16L|GIPC1_ENST00000345425.2_Silent_p.L113L	NM_005716.3	NP_005707.1	O14908	GIPC1_HUMAN	GIPC PDZ domain containing family, member 1	113		NA			endothelial cell migration|G-protein coupled receptor protein signaling pathway|glutamate secretion|negative regulation of proteasomal ubiquitin-dependent protein catabolic process|positive regulation of transforming growth factor beta receptor signaling pathway|protein targeting|regulation of protein stability|regulation of synaptic plasticity|synaptic transmission	cell cortex|dendritic shaft|dendritic spine|membrane fraction|soluble fraction|synaptic vesicle|vesicle membrane	actin binding|myosin binding|protein homodimerization activity|receptor binding			endometrium(1)|lung(4)|upper_aerodigestive_tract(1)	6						TCTGGCCCCCCAGGAGCTTGT	0.612	NA	NA					NA	NA			OREG0025316	type=REGULATORY REGION|TFbs=CTCF|Dataset=CTCF ChIP-chip sites (Ren lab)|EvidenceSubtype=ChIP-on-chip (ChIP-chip)		NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		Pancreas(33;78 923 2910 41023 52850)							NA		NA		0							NA						121	102	108	NA		NA	NA	19		NA											NA				14591540		2203	4300	6503	SO:0001819	synonymous_variant				HGNC:1226		Approved	uc002myx.4	696	A8MZG3|Q9BTC9	ENST00000393033.4	37	CCDS12310.1																																																																																			GIPC1-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000460239.2	97.740458	KEEP		-	129.230749	0.162069	47	243	---	---	---	---	1	1	121	247	0	184	57	277	0	184	2	0	0	0	0	0	0	57	277	0	184	2	TP
PTPRA	0	broad.mit.edu	37	20	2969091	2969091	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr20:2969091G>A	ENST00000216877.6	+	8	1082	c.682G>A	c.(682-684)Gac>Aac	p.D228N	PTPRA_ENST00000356147.3_Missense_Mutation_p.D228N|PTPRA_ENST00000358719.4_Missense_Mutation_p.D93N|PTPRA_ENST00000318266.5_Missense_Mutation_p.D228N|PTPRA_ENST00000399903.2_Missense_Mutation_p.D237N|PTPRA_ENST00000425918.2_Missense_Mutation_p.D248N|PTPRA_ENST00000380393.3_Missense_Mutation_p.D237N	NM_080840.2	NP_543030.1	P18433	PTPRA_HUMAN	protein tyrosine phosphatase, receptor type, A	237		NA			axon guidance|protein phosphorylation	integral to plasma membrane	transmembrane receptor protein tyrosine phosphatase activity	p.D237N(2)		NS(1)|breast(1)|endometrium(3)|large_intestine(3)|lung(5)|skin(1)|stomach(1)|upper_aerodigestive_tract(1)|urinary_tract(1)	17						AATGGCAGACGACAATAAGCT	0.507	NA	NA					NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		2	Substitution - Missense(2)	endometrium(2)					NA						111	110	110	NA		NA	NA	20		NA											NA				2969091		2203	4300	6503	SO:0001583	missense			ENSG00000132670	HGNC:9664		Approved	uc002whn.3	NA	A8K2G8|D3DVX5|Q14513|Q7Z2I2|Q96TD9	ENST00000216877.6	37	CCDS13039.1	.	.	.	.	.	.	.	.	.	.	G	35	5.564551	0.96527	.	.	ENSG00000132670	ENST00000380393;ENST00000455631;ENST00000216877;ENST00000399903;ENST00000358719;ENST00000425918;ENST00000318266;ENST00000356147	T;T;T;T;T;T;T;T	0.70045	2.78;-0.45;2.78;2.78;2.78;2.78;2.78;2.78	5.66	5.66	0.87406	.	0.000000	0.85682	U	0.000000	D	0.82444	0.5038	M	0.81682	2.555	0.80722	D	1	P;P;D;D	0.71674	0.674;0.638;0.996;0.998	B;B;D;P	0.67548	0.079;0.096;0.952;0.861	T	0.80899	-0.1176	10	0.36615	T	0.2	.	19.7589	0.96306	0.0:0.0:1.0:0.0	.	248;237;237;228	B7Z2A4;P18433-3;P18433;P18433-4	.;.;PTPRA_HUMAN;.	N	237;228;228;237;93;248;228;228	ENSP00000369756:D237N;ENSP00000414089:D228N;ENSP00000216877:D228N;ENSP00000382787:D237N;ENSP00000351559:D93N;ENSP00000393553:D248N;ENSP00000314568:D228N;ENSP00000348468:D228N	ENSP00000216877:D228N	D	+	1	0	PTPRA	2917091	1.000000	0.71417	0.997000	0.53966	0.958000	0.62258	9.604000	0.98317	2.662000	0.90505	0.557000	0.71058	GAC	PTPRA-001	KNOWN	alternative_5_UTR|basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000077682.3	84.371773	KEEP		+	91.762618	0.253731	34	100	---	---	---	---	1	1	168	237	0	81	36	109	0	81	2	0	0	0	0	0	0	36	109	0	81	2	TP
NCOA5	57727	broad.mit.edu	37	20	44698964	44698964	+	Missense_Mutation	SNP	C	C	T			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chr20:44698964C>T	ENST00000290231.6	-	3	414	c.250G>A	c.(250-252)Gtg>Atg	p.V84M		NM_020967.2	NP_066018.1	Q9HCD5	NCOA5_HUMAN	nuclear receptor coactivator 5	84	Arg/Asp-rich (mixed charge).|Transcription repression.	NA			regulation of transcription, DNA-dependent|transcription, DNA-dependent|translation	nucleus	aminoacyl-tRNA ligase activity|ATP binding			central_nervous_system(1)|endometrium(2)|kidney(3)|large_intestine(5)|liver(1)|lung(5)|ovary(1)|skin(2)|urinary_tract(1)	21		Myeloproliferative disorder(115;0.0122)				AGATCCCTCACGTCCCGAACG	0.532	NA	NA					NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA									NA		NA		0							NA						133	125	128	NA		NA	NA	20		NA											NA				44698964		2203	4300	6503	SO:0001583	missense			ENSG00000124160	HGNC:15909	NM_020967	Approved	uc002xre.3	NA	B2RTV9|E1P5R0|Q6HA99|Q9H1F2|Q9H2T2|Q9H4Y9	ENST00000290231.6	37	CCDS13392.1	.	.	.	.	.	.	.	.	.	.	C	11.68	1.709469	0.30322	.	.	ENSG00000124160	ENST00000290231	T	0.47528	0.84	4.97	1.3	0.21679	.	0.329786	0.32002	N	0.006730	T	0.22781	0.0550	N	0.08118	0	0.19575	N	0.999969	B	0.06786	0.001	B	0.01281	0.0	T	0.13980	-1.0489	10	0.30078	T	0.28	-0.1234	7.3092	0.26465	0.0:0.0794:0.4236:0.497	.	84	Q9HCD5	NCOA5_HUMAN	M	84	ENSP00000290231:V84M	ENSP00000290231:V84M	V	-	1	0	NCOA5	44132371	0.998000	0.40836	1.000000	0.80357	0.990000	0.78478	0.283000	0.18846	0.048000	0.15891	-0.247000	0.11927	GTG	NCOA5-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000079559.1	167.010516	KEEP		-	175.32739	0.293578	64	154	---	---	---	---	1	0.9999983	24	29	0	183	67	165	0	183	2	0	0	0	0	0	0	67	165	0	183	2	TP
ZRSR2	8233	broad.mit.edu	37	X	15840971	15840971	+	Missense_Mutation	SNP	G	G	A			GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	NA	NA	NA	NA	NA	NA	NA	Untested,Valid,Valid,Invalid	Somatic	Phase_I	WXS	none,rna,rna,targeted	NA	NA	Illumina GAIIx	GBM-TCGA-14-0789-Tumor-SM-1QUUR	GBM-TCGA-14-0789-Normal-SM-1QUU8	g.chrX:15840971G>A	ENST00000307771.7	+	11	1079	c.1055G>A	c.(1054-1056)cGg>cAg	p.R352Q		NM_005089.3	NP_005080.1	Q15696	U2AFM_HUMAN	zinc finger (CCCH type), RNA-binding motif and serine/arginine rich 2	352		NA			spliceosome assembly	U12-type spliceosomal complex	nucleotide binding|pre-mRNA 3'-splice site binding|protein binding|zinc ion binding			breast(3)|endometrium(2)|haematopoietic_and_lymphoid_tissue(38)|kidney(1)|large_intestine(2)|ovary(2)	48	Hepatocellular(33;0.183)					TCTCCAGATCGGACTGGCTCC	0.502	NA	NA	"""F, S, Mis"""		"""MDS, CLL"""		NA	NA						NA	NA	NA	NA	NA	NA	NA			NA	NA	NA	NA	NA	NA	NA		NA	NA	NA		NSCLC(197;1631 3042 5741 31152)		Rec	yes		X	Xp22.1	8233	"""zinc finger (CCCH type), RNA-binding motif and serine/arginine rich 2"""	NA	L	0							NA						61	58	59	NA		NA	NA	X		NA											NA				15840971		2203	4300	6503	SO:0001583	missense			ENSG00000169249	HGNC:23019	NM_005089	Approved	uc004cxg.4	NA	Q14D69	ENST00000307771.7	37	CCDS14172.1	.	.	.	.	.	.	.	.	.	.	G	17.35	3.366284	0.61513	.	.	ENSG00000169249	ENST00000307771	.	.	.	5.49	4.63	0.57726	.	0.244651	0.42682	D	0.000667	T	0.47040	0.1424	M	0.68952	2.095	0.80722	D	1	P	0.47409	0.895	B	0.36030	0.216	T	0.47873	-0.9083	9	0.29301	T	0.29	.	13.6489	0.62299	0.0765:0.0:0.9235:0.0	.	352	Q15696	U2AFM_HUMAN	Q	352	.	ENSP00000303015:R352Q	R	+	2	0	ZRSR2	15750892	1.000000	0.71417	1.000000	0.80357	0.871000	0.50021	7.588000	0.82629	1.209000	0.43321	0.600000	0.82982	CGG	ZRSR2-001	KNOWN	basic|CCDS	protein_coding	NA	protein_coding	OTTHUMT00000055889.1	146.396053	KEEP		+	146.43385	0.478261	44	48	---	---	---	---	1	1	25	11	0	89	54	56	0	89	2	0	0	0	0	0	0	54	56	0	89	2	TP
